Substance list · United Kingdom
GB mandatory classification and labelling list (GB MCL list, GB CLP Article 38A), file of 19 May 2026 (page 5)
Labelling: mandatory hazard classification, labelling, specific concentration limits, M factors and ATEs.
- When it applies
- Every substance on the list and every mixture containing it, placed on the GB market
- Entries
- 4429
- Version date
- 2026-05-19
- Guide
- United Kingdom
Entries 2001 to 2500 of 4429
500 rows
| Substance | English name | CAS | EC | Type | Category | Threshold | Conditions |
|---|---|---|---|---|---|---|---|
| reaction mass of: tetradecanoic acid (42,5-47,5 %); poly(1-7)lactate esters of tetradecanoic acid (52,5- 57,5 %) | reaction mass of: tetradecanoic acid (42,5-47,5 %); poly(1-7)lactate esters of tetradecanoic acid (52,5- 57,5 %) | 174591-51-6 | 412-580-6 | substance | Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H315; H318; H317; H410 | |
| reaction mass of: dodecanoic acid (35-40 %); poly(1-7)lactate esters of dodecanoic acid (60-65 %) | reaction mass of: dodecanoic acid (35-40 %); poly(1-7)lactate esters of dodecanoic acid (60-65 %) | 58856-63-6 | 412-590-0 | substance | Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H315; H318; H317; H410 | |
| 4-ethylamino-3-nitrobenzoic acid | 4-ethylamino-3-nitrobenzoic acid | 2788-74-1 | 412-090-2 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317; H412 | |
| trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate | trisodium N,N-bis(carboxymethyl)-3-amino-2-hydroxypropionate | 119710-96-2 | 414-130-4 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 1,2,3,4-tetrahydro-6-nitro-quinoxaline | 1,2,3,4-tetrahydro-6-nitro-quinoxaline | 41959-35-7 | 414-270-6 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| dimethylcyclopropane-1,1-dicarboxylate | dimethylcyclopropane-1,1-dicarboxylate | 6914-71-2 | 414-240-2 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate | 2-phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate | 88938-37-8 | 414-260-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 3-(cis-1-propenyl)-7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 106447-44-3 | 415-750-8 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 5-methylpyrazine-2-carboxylic acid | 5-methylpyrazine-2-carboxylic acid | 5521-55-1 | 413-260-9 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate | reaction mass of: sodium 1-tridecyl-4-allyl-(2 or 3)-sulfobutanedioate; sodium 1-dodecyl-4-allyl-(2 or 3)-sulfobutanedioate | 410-230-7 | substance | Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H314; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H317; H411 | ||
| bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate | bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4-methoxybenzylidene)malonate | 147783-69-5 | 414-840-4 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated) | reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates (branched C10-14 and C18-30 alkylated) | 415-930-6 | substance | Repr. 2; Skin Sens. 1 | Hazard statement codes: H361f***; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H361f***; H317 | ||
| ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate | ethyl N-(5-chloro-3-(4-(diethylamino)-2-methylphenylimino)-4-methyl-6-oxo-1,4-cyclohexadienyl)carbamate | 125630-94-6 | 414-820-5 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 2,2-dimethyl 3-methyl-3-butenyl propanoate | 2,2-dimethyl 3-methyl-3-butenyl propanoate | 104468-21-5 | 415-610-6 | substance | Skin Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H315; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H412 | |
| methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate | methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate | 32750-89-3 | 414-400-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate | ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate | 88805-65-6 | 414-450-4 | substance | Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H315; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H315; H318; H317 | |
| methyl N-(phenoxycarbonyl)-L-valinate | methyl N-(phenoxycarbonyl)-L-valinate | 153441-77-1 | 414-500-5 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol | reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol | 414-810-0 | substance | STOT RE 2 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H318; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H373 **; H318; H410 | ||
| reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid | reaction mass of: ((Z)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid; di-((E)-3,7-dimethyl-2,6-octadienyl) butandioate; di-((Z)-3,7-dimethyl-2,6-octadienyl) butandioate; (Z)-3,7-dimethyl-2,6-octadienyl butandioate; ((E)-3,7-dimethyl-2,6-octadienyl)oxycarbonylpropanoic acid | 415-190-4 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| 2-hexyldecyl-p-hydroxybenzoate | 2-hexyldecyl-p-hydroxybenzoate | 148348-12-3 | 415-380-7 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| potassium 2,5-dichlorobenzoate | potassium 2,5-dichlorobenzoate | 184637-62-5 | 415-700-5 | substance | Acute Tox. 4 *; Eye Dam. 1 | Hazard statement codes: H302; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318 | |
| ethyl 2-carboxy-3-(2-thienyl)propionate | ethyl 2-carboxy-3-(2-thienyl)propionate | 143468-96-6 | 415-680-8 | substance | Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H315; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H315; H318; H317 | |
| potassium N-(4-fluorophenyl)glycinate | potassium N-(4-fluorophenyl)glycinate | 184637-63-6 | 415-710-1 | substance | STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H373 **; H318; H317; H412. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H373 **; H318; H317; H412 | |
| reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus | reaction mass of: (3R)-[1S-(1α, 2α, 6β-((2S)-2-methyl-1-oxo-butoxy)-8aγ)hexahydro-2,6-dimethyl-1-naphthalene]-3,5-dihydroxyheptanoic acid; inert biomass from Aspergillus terreus | 415-840-7 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | ||
| mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen- 3-(hexadec-2-enyl)butanedioate | mono[2-(dimethylamino)ethyl]monohydrogen-2-(hexadec-2-enyl)butanedioate and/or mono[2-(dimethylamino)ethyl]monohydrogen- 3-(hexadec-2-enyl)butanedioate | 779343-34-9 | 415-880-5 | substance | Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H315; H318; H317; H410 | |
| oxiranemethanol, 4-methylbenzene-sulfonate, (S)- | oxiranemethanol, 4-methylbenzene-sulfonate, (S)- | 70987-78-9 | 417-210-7 | substance | Carc. 1B; Muta. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H318; H317; H411. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H341; H318; H317; H411 | |
| ethyl 2-(1-cyanocyclohexyl)acetate | ethyl 2-(1-cyanocyclohexyl)acetate | 133481-10-4 | 415-970-4 | substance | Acute Tox. 4 *; STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H302; H373 **; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H302; H373 **; H412 | |
| trans-4-phenyl-L-proline | trans-4-phenyl-L-proline | 96314-26-0 | 416-020-1 | substance | Repr. 2; Skin Sens. 1 | Hazard statement codes: H361f ***; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H361f ***; H317 | |
| poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α,α-dimethylbenzyl carbamate)-co-(maleicanhydride) | poly-(methyl methacrylate)-co-(butylmethacrylate)-co-(4-acryloxybutyl-isopropenyl-α,α-dimethylbenzyl carbamate)-co-(maleicanhydride) | 419-590-1 | substance | Flam. Sol. 1; Skin Sens. 1 | Hazard statement codes: H228; H317. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H228; H317. Notes: T | ||
| 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide | 4-(2-carboxymethylthio)ethoxy-1-hydroxy-5-isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2-naphthamide | 420-730-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| 3-chloropropyl chloroformiate | 3-chloropropyl chloroformiate | 628-11-5 | 425-770-9 | substance | Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 2 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H331; H302; H373**; H315; H318; H317. Labelling pictogram and signal word: GHS06; GHS05; GHS08; Dgr. Labelling hazard statements: H331; H302; H373**; H315; H318; H317 | |
| 2-ethylhexyl 4-aminobenzoate | 2-ethylhexyl 4-aminobenzoate | 26218-04-2 | 420-170-3 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid | (3'-carboxymethyl-5-(2-(3-ethyl-3H-benzothiazol-2-ylidene)-1-methyl-ethylidene)-4,4'-dioxo-2'-thioxo-(2,5')bithiazolidinyliden-3-yl)-acetic acid | 166596-68-5 | 422-240-9 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| 2,2-bis(hydroxymethyl)butanoic acid | 2,2-bis(hydroxymethyl)butanoic acid | 10097-02-6 | 424-090-1 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovi-nyl)-2,2-dimethylcyclopro-panecarboxylate; cypermethrin cis/trans +/- 40/60 | cypermethrin (ISO); α-cyano-3-phenoxybenzyl 3-(2,2-dichlorovi-nyl)-2,2-dimethylcyclopro-panecarboxylate; cypermethrin cis/trans +/- 40/60 | 52315-07-8 | 257-842-9 | substance | Acute Tox. 4; Acute Tox. 4; STOT SE 3; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | Inhalation: ATE = 3.3 mg/L (dusts/mists) | Oral: ATE = 500 mg/kg bw | M = 100000 | M = 100000 | Hazard statement codes: H332; H302; H335; H373 (nervous system); H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Wng. Labelling hazard statements: H332; H302; H335; H373 (nervous system); H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| α-cypermethrin (ISO); racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S, 3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | α-cypermethrin (ISO); racemate comprising (R)-α-cyano-3-phenoxybenzyl (1S, 3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; (S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 67375-30-8 | 257-842-9 | substance | Acute Tox. 3 *; STOT RE 2 *; STOT SE 3; Aquatic Acute 1; Aquatic Chronic 1 | M=1000 | Hazard statement codes: H301; H373**; H335; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H373 **; H335; H410 |
| esters of mecoprop and of mecoprop-P | esters of mecoprop and of mecoprop-P | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410. Notes: A | |||
| trifloxystrobin (ISO); methyl (E)-methoxyimino- {(E)-α-[1-(α,α,α-trifluoro-m- tolyl) ethylideneaminooxy]-o- tolyl}acetate | trifloxystrobin (ISO); methyl (E)-methoxyimino- {(E)-α-[1-(α,α,α-trifluoro-m- tolyl) ethylideneaminooxy]-o- tolyl}acetate | 141517-21-7 | substance | Lact.; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H362; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H362; H317; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate | metalaxyl (ISO); methyl-N-(2,6-dimethylphenyl)-N-(methoxyacetyl)-DL-alaninate | 57837-19-1 | 260-979-7 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317; H412 | |
| 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1] n-pentyl-isopentylphthalate; [2] di-n-pentyl phthalate; [3] diisopentylphthalate [4] | 1,2-benzenedicarboxylic acid, dipentylester, branched and linear; [1] n-pentyl-isopentylphthalate; [2] di-n-pentyl phthalate; [3] diisopentylphthalate [4] | 84777-06-0 [1] - [2] 131-18-0 [3] 605-50-5 [4] | 284-032-2 [1] - [2] 205-017-9 [3] 210-088-4 [4] | substance | Repr. 1B; Aquatic Acute 1 | Hazard statement codes: H360FD; H400. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360FD; H400 | |
| bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate | bromoxynil heptanoate (ISO); 2,6-dibromo-4-cyanophenyl heptanoate | 56634-95-8 | 260-300-4 | substance | Repr. 2; Acute Tox. 4 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H361d ***; H332; H302; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361d ***; H332; H302; H317; H410 | |
| tetrasodium ethylene diamine tetraacetate | tetrasodium ethylene diamine tetraacetate | 64-02-8 | 200-573-9 | substance | Acute Tox. 4 *; Eye Dam. 1 | Hazard statement codes: H302; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318 | |
| edetic acid; (EDTA) | edetic acid; (EDTA) | 60-00-4 | 200-449-4 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| BBP; benzyl butyl phthalate e | BBP; benzyl butyl phthalate e | 85-68-7 | 201-622-7 | substance | Repr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360Df; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360Df; H410 | |
| prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate | prallethrin (ISO); ETOC; 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate | 23031-36-9 | 245-387-9 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H302; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H302; H410 | |
| S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (R a S a)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide] | S-metolachlor (ISO); 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide; (R a S a)-2-chloro-N-(6-ethyl-o-tolyl)-N-[(1S)-2-methoxy-1-methylethyl]acetamide [contains 80-100 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2S)-1-methoxypropan-2-yl]acetamide and 0-20 % 2-chloro-N-(2-ethyl-6-methylphenyl)-N-[(2R)-1-methoxypropan-2-yl]acetamide] | 87392-12-9 | substance | Carc. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 10 | Hazard statement codes: H351; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H317; H410. Supplementary hazard statements: EUH066. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| cypermethrin cis/trans +/- 80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | cypermethrin cis/trans +/- 80/20; (RS)-α-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 52315-07-8 | 257-842-9 | substance | Acute Tox. 4 *; STOT SE 3; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H335; H315; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H335; H315; H317; H410 | |
| mecoprop-P [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy)propionic acid and its salts | mecoprop-P [1] and its salts; (R)-2-(4-chloro-2-methylphenoxy)propionic acid and its salts | 16484-77-8 | 240-539-0 | substance | Acute Tox. 4; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Oral: ATE = 431 mg/kg bw | M = 10 | M = 1 | Hazard statement codes: H302; H318; H400; H410. Labelling pictogram and signal word: GHS07; GHS05; GHS09; Dgr. Labelling hazard statements: H302; H318; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate | 2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate | 111969-64-3 | 416-810-6 | substance | STOT RE 2 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H373 **; H318; H411. Labelling pictogram and signal word: GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H373 **; H318; H411 | |
| 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate | 2-hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl neodecanoate | 417-350-9 | substance | Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H315; H318; H410 | ||
| 3-(4-aminophenyl)-2-cyano-2-propenoic acid | 3-(4-aminophenyl)-2-cyano-2-propenoic acid | 252977-62-1 | 417-480-6 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| methyl-2-[(aminosulfonyl)methyl]benzoate | methyl-2-[(aminosulfonyl)methyl]benzoate | 112941-26-1 | 419-010-5 | substance | Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H302; H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319 | |
| methyl tetrahydro-2-furancarboxylate | methyl tetrahydro-2-furancarboxylate | 37443-42-8 | 420-670-1 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate | methyl 2-aminosulfonyl-6-(trifluoromethyl)pyridine-3-c arboxylate | 144740-59-0 | 421-220-7 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid | 3-[3-(2-dodecyloxy-5-methylphenylcarbamoyl)-4-hydroxy-1-naphthylthio]propionic acid | 167684-63-1 | 421-490-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate | benzyl [hydroxy-(4-phenylbutyl)phosphinyl] acetate | 87460-09-1 | 416-050-5 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate; trans-1,4-dimethylcyclohexyl dibenzoate | reaction mass of: cis-1,4-dimethylcyclohexyl dibenzoate; trans-1,4-dimethylcyclohexyl dibenzoate | 35541-81-2 | 416-230-3 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| Iron (III) tris(4-methylbenzenesulfonate) | Iron (III) tris(4-methylbenzenesulfonate) | 77214-82-5 | 420-960-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate | methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1-oxopropyl)amino]phenylaminopropionate | 155522-12-6 | 416-240-8 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate | sodium 4-[4-(4-hydroxyphenylazo)phenylamino]-3-nitrobenzenesulfonate | 156738-27-1 | 416-370-5 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| 2,3,5,6-tetrafluorobenzoic acid | 2,3,5,6-tetrafluorobenzoic acid | 652-18-6 | 416-800-1 | substance | Skin Irrit. 2; Eye Dam. 1 | Hazard statement codes: H315; H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H315; H318 | |
| reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl) iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate]; 4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1- ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] | reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl) iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate]; 4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1- ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] | 417-080-1 | substance | Self-react. D****; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H242; H317; H400; H410. Labelling pictogram and signal word: GHS02; GHS07; GHS09; Dgr. Labelling hazard statements: H242; H317; H410 | ||
| 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol- 4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate | 2-mercaptobenzothiazolyl-(Z)-(2-aminothiazol- 4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate | 89604-92-2 | 419-040-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-ulfoxyethylsulfonyl) phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt | 4-[4-amino-5-hydroxy-3-(4-(2-sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-ulfoxyethylsulfonyl) phenylazo)-2,7-disulfonapht-6-ylazo]phenylcarbonylamino]benzenesulfonic acid, sodium salt | 161935-19-9 | 417-640-5 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate) | 4-benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2-dimethyloctanoate) | 172964-15-7 | 418-100-1 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid; cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid | reaction mass of: trans-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid; cis-2-(1-methylethyl)-1,3-dioxane-5-carboxylic acid | 116193-72-7 | 418-170-3 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt | 1-amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)-1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)-anthraquinone-2-sulfonic acid, sodium/lithium salt | 172890-93-6 | 419-520-8 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 3-amino-4-chlorobenzoic acid, hexadecyl ester | 3-amino-4-chlorobenzoic acid, hexadecyl ester | 143269-74-3 | 419-700-6 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) | tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}-1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene-1',3,6-trisulfonate) | 172277-97-3 | 420-350-1 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | |
| reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate; 2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate; 2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]] | reaction mass of: 2-ethyl-[2,6-dibromo-4-[1-[3,5-dibromo-4-(2-hydroxyethoxy)phenyl]-1-methylethyl]phenoxy]propenoate; 2,2'-diethyl-[4,4'-bis(2,6-dibromophenoxy)-1-methylethylidene] dipropenoate; 2,2'-[(1-methylethylidene)bis[[2,6-dibromo-4,1-phenylene)oxy]ethanol]] | 420-850-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino} benzoate | isopentyl 4-{2-[5-cyano-1,2,3,6-tetrahydro-1-(2-isopropoxyethoxy-carbonylmethyl)-4-methyl-2,6-dioxo-3-pyridylidene]hydrazino} benzoate | 418-930-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| 3-tridecyloxy-propyl-ammonium 9-octadecenoate | 3-tridecyloxy-propyl-ammonium 9-octadecenoate | 778577-53-0 | 418-990-1 | substance | STOT RE 2 *; Eye Irrit. 2; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373 **; H319; H315; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H373 **; H319; H315; H410 | |
| reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate; pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)- phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate | reaction mass of: pentasodium 2-{4-{3-methyl-4-[6-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)-phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate; pentasodium 2-{4-{3-methyl-4-[7-sulfonato-4-(2-sulfonato-phenylazo)-naphthalen-1-ylazo]-phenylamino}-6-[3-(2-sulfato-ethanesulfonyl)- phenylamino]-1,3,5-triazin-2-ylamino}-benzene-1,4-disulfonate | 421-160-1 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| reaction mass of: 1-hexyl acetate; 2-methyl-1-pentyl acetate; 3-methyl-1-pentyl acetate; 4-methyl-1-pentyl acetate; other mixed linear and branched C6-alkyl acetates | reaction mass of: 1-hexyl acetate; 2-methyl-1-pentyl acetate; 3-methyl-1-pentyl acetate; 4-methyl-1-pentyl acetate; other mixed linear and branched C6-alkyl acetates | 88230-35-7 | 421-230-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 3-(phenothiazin-10-yl)propionic acid | 3-(phenothiazin-10-yl)propionic acid | 362-03-8 | 421-260-5 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid | reaction mass of: 7-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid; 5-chloro-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid | 421-280-4 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo} naphthalene-1,3-disulfonate | tris(2-hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2-ethoxy-phenylazo} naphthalene-1,3-disulfonate | 778583-04-3 | 421-440-3 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-etrahydrobenzotriazole-5-carboxylate; phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate | reaction mass of: phenyl 1-(1-[2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl]-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-etrahydrobenzotriazole-5-carboxylate; phenyl 2-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate; phenyl 3-(1-(2-chloro-5-(hexadecyloxycarbonyl)phenylcarbamoyl)-3,3-dimethyl-2-oxobutyl)-1H-2,3,3a,7a-tetrahydrobenzotriazole-5-carboxylate | 421-480-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate | 1,1,3,3-tetrabutyl-1,3-ditinoxydicaprylate | 56533-00-7 | 419-430-9 | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H373 **; H314; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H373 **; H314; H410 | |
| reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5- sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5- sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5- sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate | reaction mass of: monosodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5-sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; disodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5- sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; trisodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5- sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate; tetrasodium 4-((4-(5-sulfonato-2-methoxyphenylamino)-6-chloro-1,3,5-triazine-2-yl)amino)-2-((1,4-dimethyl-6-oxido-2-oxo-5- sulfonatomethyl-1,2-dihydropyridine-3-yl)azo)benzenesulfonate | 419-450-8 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)- 2-naphthalene sulfonate | disodium 7-((4,6-bis(3-diethylaminopropylamino)-1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-sulfonatophenylazo)phenylazo)- 2-naphthalene sulfonate | 120029-06-3 | 419-460-2 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| potassium sodium 6,13-dichloro-3,10-bis {2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | potassium sodium 6,13-dichloro-3,10-bis {2-[4-[3-(2-hydroxysulphonyloxyethanesulfonyl)phenylamino]-6-(2,5-disulfonatophenylamino)-1,3,5-triazin-2-ylamino]ethylamino}benzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | 154336-20-6 | 414-100-0 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| 1,6-bis((dibenzylthiocarbamoyl) disulfanyl)hexane | 1,6-bis((dibenzylthiocarbamoyl) disulfanyl)hexane | 151900-44-6 | 429-280-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid | pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid | 187412-41-5 | 426-590-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid | (4-(4-(4-dimethylaminobenzyliden-1-yl)-3-methyl-5-oxo-2-pyrazolin-1-yl)benzoic acid | 117573-89-4 | 410-430-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo) naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) | reaction mass of: tetrasodium 7-(4-[4-chloro-6-[methyl-(3-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo) naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-[4-chloro-6-[methyl-(4-sulfonatophenyl)amino]-1,3,5-triazin-2-ylamino]-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate (1:1) | 148878-18-6 | 412-940-2 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| trisodium N,N-bis(carboxymethyl)-β-alanine | trisodium N,N-bis(carboxymethyl)-β-alanine | 129050-62-0 | 414-070-9 | substance | Skin Corr. 1B; Aquatic Chronic 3 | Hazard statement codes: H314; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314; H412 | |
| (1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt | (1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt | 426-740-8 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H411 | ||
| tetramethylammonium hydrogen phthalate | tetramethylammonium hydrogen phthalate | 79723-02-7 | 416-900-5 | substance | Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1 | Hazard statement codes: H301; H373 **; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H373 **; H400 | |
| hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate | hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxopentamido]benzoate | 168689-49-4 | 418-550-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 1,2-benzenedicarboxylic acid; di-C7-11-branched and linear alkylesters | 1,2-benzenedicarboxylic acid; di-C7-11-branched and linear alkylesters | 68515-42-4 | 271-084-6 | substance | Repr. 1B | Hazard statement codes: H360Df. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360Df | |
| reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate | reaction mass of: trihexyl citrate; dihexyloctyl citrate; dioctylhexyl citrate; dihexyldecyl citrate | 430-290-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride | N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride | 84793-24-8 | 430-360-8 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| 1,2-benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich | 1,2-benzenedicarboxylic acid; di-C6-8-branched alkylesters, C7-rich | 71888-89-6 | 276-158-1 | substance | Repr. 1B | Hazard statement codes: H360D***. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D*** | |
| ethyl 2-{][}3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate | ethyl 2-{][}3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate | 221452-67-1 | 430-480-0 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| (3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate | (3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate | 430-510-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| potassium sodium 5’-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino) -1,3,5-triazin-2-ylamino)-4’-hydroxy-2,3’-azodinaphthalene-1,2’, 5,7’-disulfonate | potassium sodium 5’-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino) -1,3,5-triazin-2-ylamino)-4’-hydroxy-2,3’-azodinaphthalene-1,2’, 5,7’-disulfonate | 110081-40-8 | 402-110-8 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5- dihydro-5-oxopyrazol-1-yl)benzenesulfonate | reaction mass of: disodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5-dihydro-5-oxopyrazol-1-yl)benzenesulfonate; trisodium 4-(3-ethoxycarbonyl-4-(5-(3-ethoxycarbonyl-5-oxido-1-(4-sulfonatophenyl)pyrazol-4-yl)penta-2,4-dienylidene)-4,5- dihydro-5-oxopyrazol-1-yl)benzenesulfonate | 402-660-9 | substance | Repr. 1B; Aquatic Chronic 3 | Hazard statement codes: H360D ***; H412. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D ***; H412 | ||
| ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate | ethyl (2-acetylamino-5-fluoro-4-isothiocyanatophenoxy)acetate | 147379-38-2 | 414-210-9 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate; 2-ethylhexyl epoxyoleate; 2-ethylhexyl diepoxylinoleate; 2-ethylhexyl triepoxylinolenate | reaction mass of: 2-ethylhexyl linolenate, linoleate and oleate; 2-ethylhexyl epoxyoleate; 2-ethylhexyl diepoxylinoleate; 2-ethylhexyl triepoxylinolenate | 71302-79-9 | 414-890-7 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate | N-[2-hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl glycinate | 415-060-7 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| reaction mass of: diester of 4,4’-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4’-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3) | reaction mass of: diester of 4,4’-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2); triester of 4,4’-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3) | 427-140-9 | substance | Carc. 2 | Hazard statement codes: H351. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H351 | ||
| 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate | 2-(1-(3',3'-dimethyl-1'-cyclohexyl)ethoxy)-2-methyl propyl propanoate | 141773-73-1 | 415-490-5 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano [3,4-d]oxazole-6-carboxylate | methyl (3aR,4R,7aR)-2-methyl-4-(1S,2R,3-triacetoxypropyl)-3a,7a-dihydro-4H-pyrano [3,4-d]oxazole-6-carboxylate | 78850-37-0 | 415-670-3 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| bis(2-ethylhexyl)octylphosphonate | bis(2-ethylhexyl)octylphosphonate | 52894-02-7 | 417-170-0 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate | sodium 4-sulfophenyl-6-((1-oxononyl)amino)hexanoate | 168151-92-6 | 417-550-6 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite | 2,2'-methylenebis(4,6-di-tert-butyl-phenyl)-2-ethylhexyl phosphite | 126050-54-2 | 418-310-3 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| cerium oxide isostearate | cerium oxide isostearate | 419-760-3 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| (E)-3,7-dimethyl-2,6-octadienylhexadecanoate | (E)-3,7-dimethyl-2,6-octadienylhexadecanoate | 3681-73-0 | 421-370-3 | substance | Skin Irrit. 2; Aquatic Chronic 4 | Hazard statement codes: H315; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H413 | |
| bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) | bis(dimethyl-(2-hydroxyethyl)ammonium) 1,2-ethanediyl-bis(2-hexadecenylsuccinate) | 421-660-1 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H411 | ||
| calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate | calcium 2,2,bis[(5-tetrapropylene-2-hydroxy)phenyl]ethanoate | 421-670-4 | substance | Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H410 | ||
| reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives | reaction mass of: triphenylthiophosphate and tertiary butylated phenyl derivatives | 192268-65-8 | 421-820-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| (N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate | (N-benzyl-N,N,N-tributyl)ammonium 4-dodecylbenzenesulfonate | 178277-55-9 | 422-200-0 | substance | Skin Corr. 1B; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H314; H302; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H302; H411 | |
| 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane | 2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane | 68957-94-8 | 422-210-5 | substance | Skin Corr. 1B | Hazard statement codes: H314. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314 | |
| diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate | diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate | 422-670-7 | substance | Repr. 2; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H361f; H301; H373**; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H361f; H301; H373**; H410 | ||
| pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate | pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-chloro-1,3,5-triazin-2-yl)amino-2-ureidophenylazo)naphtalene-1,3,6-trisulfonate | 422-930-1 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl) benzenesulfonate; disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1Hpyrazol-4-yl)azo)-5-methyl)benzenesulfonate | reaction mass of: strontium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1H-pyrazol-4-yl)azo)-5-methyl) benzenesulfonate; disodium (4-chloro-2-((4,5-dihydro-3-methyl-5-oxo-1-(3-sulfonatophenyl)-1Hpyrazol-4-yl)azo)-5-methyl)benzenesulfonate | 422-970-8 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate | potassium,sodium 2,4-diamino-3-[4-(2-sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2-sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]-benzenesulfonate | 187026-95-5 | 422-980-2 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] | disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-phenylenesulfonylimino-(4-amino-6-hydroxypyrimidine-2,5-diyl)azo-4,1-phenylenesulfonylimino(4-amino-6-hydroxypyrimidine-2,5-diyl)azo]bis(benzenesulfonate)] | 423-110-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| 2-phenoxyethyl 4-aminobenzoate | 2-phenoxyethyl 4-aminobenzoate | 88938-23-2 | 430-880-5 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| (2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide | (2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide | 76646-91-8 | 427-200-4 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H315; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H315; H318; H317 | |
| reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid | reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid; 4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid | 423-750-4 | substance | Eye Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H319; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H411 | ||
| trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate | trisodium 2,4-diamino-3,5-bis-[4-(2-sulfonatoethoxy)sulfonyl)phenylazo]benzenesulfonate | 182926-43-8 | 423-970-0 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfatonaphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid | reaction mass of: trisodium 4-benzoylamino-6-(6-ethenesulfonyl-1-sulfatonaphthalen-2-ylazo)-5-hydroxynaphthalene-2,7-disulfonate; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid sodium salt; 5-(benzoylamino)-4-hydroxy-3-((1-sulfo-6-((2-(sulfooxy)ethyl)sulfonyl)-2-naphthyl)azo)naphthalene-2,7-disulfonic acid | 423-200-3 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | ||
| potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate | potassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate | 134841-35-3 | 427-240-2 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate | reaction mass of: disodium hexyldiphenyl ether disulphonate; disodium dihexyldiphenyl ether disulphonate | 147732-60-3 | 429-650-7 | substance | Eye Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H319; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H411 | |
| N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine | N,N'-bis(trifluoroacetyl)-S,S'-bis-L-homocysteine | 105996-54-1 | 429-670-6 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| (S)-α-(acetylthio)benzenepropanoic acid | (S)-α-(acetylthio)benzenepropanoic acid | 76932-17-7 | 430-300-0 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H317 | |
| 3-oxoandrost-4-ene-17-β-carboxylic acid | 3-oxoandrost-4-ene-17-β-carboxylic acid | 302-97-6 | 414-990-0 | substance | Repr. 2; Aquatic Chronic 4 | Hazard statement codes: H361f; H413. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H361f; H413 | |
| poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl) cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl) cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | 176429-27-9 | 427-280-0 | substance | STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H335; H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H335; H315; H318; H410 | |
| reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate | reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate; disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate | 427-740-0 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| tetraethyl N,N’-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate | tetraethyl N,N’-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate | 136210-30-5 | 429-270-1 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate | sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate | 184246-86-4 | 429-720-7 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B’]di[1,4] benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B’]di[1,4] benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10’-diamino-6,6’, 13,13’-tetrachloro-3,3’-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo [1,2-B:4,5-B’]di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6’, 13,13’-tetrachloro-10’[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo [1,2-B:4,5-B’]di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10’-diamino-6,6’, 3,3’ [(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino] bis[benzo[1,2-B:4,5-B’]di[1,4] benzoxazine-4,11-disulfonate | reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B’]di[1,4] benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B’]di[1,4] benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10’-diamino-6,6’, 13,13’-tetrachloro-3,3’-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo [1,2-B:4,5-B’]di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6’, 13,13’-tetrachloro-10’[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo [1,2-B:4,5-B’]di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10’-diamino-6,6’, 3,3’ [(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino] bis[benzo[1,2-B:4,5-B’]di[1,4] benzoxazine-4,11-disulfonate | 430-200-7 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters | tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters | 430-310-5 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling hazard statements: H413 | ||
| (Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid | (Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid | 64485-90-1 | 431-520-1 | substance | Flam. Sol. 1****; Carc. 2; Aquatic Chronic 3 | Hazard statement codes: H228; H351; H412. Labelling pictogram and signal word: GHS02; GHS08; Dgr. Labelling hazard statements: H228; H351; H412 | |
| cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propane | cartap (ISO); 1,3-bis(carbamoylthio)-2-(dimethylamino)propane | 15263-53-3 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate | reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate | 423-180-6 | substance | STOT RE 2 * | Hazard statement codes: H373 **. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H373 ** | ||
| (S)-3-methyl-2-(2-oxotetrahydropyrimidine -1-yl)butyric acid | (S)-3-methyl-2-(2-oxotetrahydropyrimidine -1-yl)butyric acid | 192725-50-1 | 430-900-2 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| benzyl cis-4-ammonium-4’-toluenesulfonato-1-cyclohexanecarboxylate | benzyl cis-4-ammonium-4’-toluenesulfonato-1-cyclohexanecarboxylate | 67299-45-0 | 426-070-6 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate | reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propionate | 125643-61-0 | 406-040-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| methyl 3-amino-4,6-dibromo-2-methyl-benzoate | methyl 3-amino-4,6-dibromo-2-methyl-benzoate | 119916-05-1 | 425-190-6 | substance | STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H373**; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373**; H411 | |
| (S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt | (S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt | 167944-94-7 | 425-510-4 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate | 414-910-4 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| ethyl 2-(3-benzoylphenyl)propanoate | ethyl 2-(3-benzoylphenyl)propanoate | 60658-04-0 | 414-920-9 | substance | Acute Tox. 3 *; STOT RE 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H301; H372**; H317; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H372**; H317; H411 | |
| potassium 4-iodo-2-sulfonato-benzoic acid | potassium 4-iodo-2-sulfonato-benzoic acid | 426-620-5 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| (2,6-xylyloxy) acetic acid | (2,6-xylyloxy) acetic acid | 13335-71-2 | 430-910-7 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H412 | |
| isopropylammonium 2-(3-benzoylphenyl)propionate | isopropylammonium 2-(3-benzoylphenyl)propionate | 417-970-1 | substance | Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 1; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H312; H372**; H318; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H312; H372**; H318; H410 | ||
| propyl((4-(5-oxo-3-propylisoxazolidin -4-ylidenmethin)phenyl) propoxycarbonylmethyleneamino) acetate | propyl((4-(5-oxo-3-propylisoxazolidin -4-ylidenmethin)phenyl) propoxycarbonylmethyleneamino) acetate | 198705-81-6 | 431-000-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 1-(mercaptomethyl)cyclopropylacetic acid | 1-(mercaptomethyl)cyclopropylacetic acid | 162515-68-6 | 420-240-3 | substance | Skin Corr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H314; H312; H302; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H312; H302; H317; H411 | |
| [(1-methyl-1,2-ethanediyl) bis[nitrilobis(methylene)]]tetrakis(phosphonic acid) | [(1-methyl-1,2-ethanediyl) bis[nitrilobis(methylene)]]tetrakis(phosphonic acid) | 28698-31-9 | 421-940-1 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | |
| methyl 2-(4-butanesulfonamidophenoxy) tetradecanoate | methyl 2-(4-butanesulfonamidophenoxy) tetradecanoate | 422-110-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate] | 176429-22-4 | 427-480-8 | substance | STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H335; H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H335; H315; H318; H410 | |
| ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate | ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate | 158585-86-5 | 427-490-2 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate | 1,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate | 94346-09-5 | 424-070-0 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | |
| reaction mass of: methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{] methoxycarbonylmethylamino[} acetate; methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{] ethoxycarbonylmethylamino[}acetate | reaction mass of: methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{] methoxycarbonylmethylamino[} acetate; methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{] ethoxycarbonylmethylamino[}acetate | 188070-47-5 | 424-290-7 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 18-methylnonadecyl 2,2-dimethylpropanoate | 18-methylnonadecyl 2,2-dimethylpropanoate | 125496-22-2 | 424-370-1 | substance | Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H315; H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H317; H413 | |
| 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate | 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate | 154486-26-7 | 431-010-7 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H411 | |
| methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate | methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate | 125778-19-0 | 424-430-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 2-amino-4-bromo-5-chlorobenzoic acid | 2-amino-4-bromo-5-chlorobenzoic acid | 424-700-4 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | ||
| tetrabutylammonium 2-amino-6-iodopurinate | tetrabutylammonium 2-amino-6-iodopurinate | 156126-48-6 | 424-710-9 | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H312; H302; H373**; H315; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H373**; H315; H318; H317; H411 | |
| hexadecyl 3-amino-4-isopropoxybenzoate | hexadecyl 3-amino-4-isopropoxybenzoate | 424-830-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| 7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6 (or 7)-sulfo-1-naphthyl]azo]phenyl] amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt | 7-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6 (or 7)-sulfo-1-naphthyl]azo]phenyl] amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt | 424-850-0 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| 2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid | 2,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid | 27624-67-5 | 424-870-1 | substance | Expl. 1.1; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H201; H318; H412. Labelling pictogram and signal word: GHS01; GHS05; Dgr. Labelling hazard statements: H201; H318; H412 | |
| 1,1,3,3-tetramethylbutylperoxypivalate | 1,1,3,3-tetramethylbutylperoxypivalate | 22288-41-1 | 424-980-8 | substance | Flam. Liq. 2; Org. Perox. D; Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H225; H242; H315; H317; H411. Labelling pictogram and signal word: GHS02; GHS07; GHS09; Dgr. Labelling hazard statements: H225; H242; H315; H317; H411 | |
| 2-acetoxymethylene-4-acetylphenylacetate | 2-acetoxymethylene-4-acetylphenylacetate | 24085-06-1 | 425-160-2 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H373**; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H373**; H318; H317; H410 | |
| salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid | salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid | 169939-84-8 | 425-210-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate | 2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate | 147027-10-9 | 425-250-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid | coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid | 179986-09-5 | 425-400-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| (R,S)-2-butyloctanedioic acid | (R,S)-2-butyloctanedioic acid | 50905-10-7 | 431-210-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| sodium 4-hydroxy-3-(N’-(2-(2-hydroxyethylenesulfonyl) ethylene)ureido)-5-nitrobenzenesulfonate | sodium 4-hydroxy-3-(N’-(2-(2-hydroxyethylenesulfonyl) ethylene)ureido)-5-nitrobenzenesulfonate | 425-460-3 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | ||
| reaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate | reaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate; (2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate | 98769-75-6 | 425-530-3 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H411 | |
| 5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid | 5,7-dichloro-4-hydroxyquinoline-3-carboxylic acid | 171850-30-9 | 431-250-2 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate | 1,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate | 51178-75-7 | 425-730-0 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate | 3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate | 88150-42-9 | 425-820-1 | substance | Acute Tox. 3 *; STOT RE 2 *; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H373**; H318; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS08; GHS09; Dg. Labelling hazard statements: H301; H373**; H318; H410 | |
| reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate | reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate; bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate | 426-140-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| potassium 3-iodo-6-methylbenzenesulfonate | potassium 3-iodo-6-methylbenzenesulfonate | 426-300-5 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| potassium 2-chloro-3-(benzyloxy)propionate | potassium 2-chloro-3-(benzyloxy)propionate | 138666-92-9 | 426-350-8 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H373**; H318; H317. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H302; H373**; H318; H317 | |
| reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate | reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate; sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate | 426-470-0 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl] thio]methyl]-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate monohydrate | sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl] thio]methyl]-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate monohydrate | 71420-85-4 | 426-520-1 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate | 2-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate | 57374-49-9 | 431-400-7 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate | diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate | 162208-27-7 | 426-790-0 | substance | Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H373**; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H373**; H317; H410 | |
| reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate | reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate; disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate | 426-840-1 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| [1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl] butanedioate | [1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl] butanedioate | 77341-67-4 | 426-890-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt | 4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt | 426-900-7 | substance | STOT SE 3; Aquatic Chronic 3 | Hazard statement codes: H335; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H335; H412 | ||
| branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate | branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate | 427-030-0 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| (2R*, 3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate | (2R*, 3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate | 427-100-0 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H317; H412 | ||
| ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate | ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate | 427-110-5 | substance | Acute Tox. 4 *; STOT RE 2 *; Aquatic Chronic 4 | Hazard statement codes: H302; H373**; H413. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H302; H373**; H413 | ||
| diethyl[(p-ethoxyanilino)methylene]malonate | diethyl[(p-ethoxyanilino)methylene]malonate | 103976-28-9 | 431-430-0 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate | ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate | 100491-29-0 | 422-360-1 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| ethyl 2-ethoxy-4-carboxymethylbenzoate | ethyl 2-ethoxy-4-carboxymethylbenzoate | 99469-99-5 | 427-630-2 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate; tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | 427-650-1 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| 4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid | 4-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid | 188907-52-0 | 427-680-5 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | |
| trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl) phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate | trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl) phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate | 215612-56-9 | 427-710-7 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | |
| strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate | strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate | 427-930-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| dodecyl 3-amino-4-chlorobenzoate | dodecyl 3-amino-4-chlorobenzoate | 6195-20-6 | 428-020-9 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate | ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate | 67914-69-6 | 428-030-3 | substance | Acute Tox. 4 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H373**; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373**; H410 | |
| reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate | reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate; bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate | 428-050-2 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | ||
| tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate | tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate | 91788-83-9 | 428-070-1 | substance | STOT RE 1; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H372**; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H372**; H302; H410 | |
| hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate | hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate | 210706-50-6 | 428-140-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: trisodium 5-(4-fluoro- 6-morpholin-4-yl-1,3,5-triazin-2- ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene- 2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl- 1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate | reaction mass of: trisodium 5-(4-fluoro- 6-morpholin-4-yl-1,3,5-triazin-2- ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene- 2,7-disulfonate; disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl- 1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate | 428-400-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate | di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate | 428-870-0 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| 4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate | 4-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate | 159235-16-2 | 429-000-2 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| ethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate | ethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate | 204254-96-6 | 429-020-1 | substance | STOT RE 2 *; Skin Sens. 1 | Hazard statement codes: H373**; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H373**; H317 | |
| N-amidino-N-methylglycine-2-oxopropionate | N-amidino-N-methylglycine-2-oxopropionate | 208535-04-0 | 429-120-5 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| ethyl 2-(4-phenoxyphenyl)lactate | ethyl 2-(4-phenoxyphenyl)lactate | 132584-17-9 | 429-220-9 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| tetrasodium 4,4’-bis{]4-[}4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino{]phenylazo[}stilbene-2,2’-disulfonate | tetrasodium 4,4’-bis{]4-[}4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino{]phenylazo[}stilbene-2,2’-disulfonate | 429-230-3 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | ||
| trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate | trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate | 212652-59-0 | 429-240-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate | 1,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate | 68860-54-8 | 431-610-9 | substance | Org. Perox. D; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H242; H317; H400; H410. Labelling pictogram and signal word: GHS02; GHS07; GHS09; Dgr. Labelling hazard statements: H242; H317; H410 | |
| (1S, 1’R)-[1-(3’, 3’-dimethyl-1’-cyclohexyl)ethoxycarbonyl]methyl propanoate | (1S, 1’R)-[1-(3’, 3’-dimethyl-1’-cyclohexyl)ethoxycarbonyl]methyl propanoate | 431-700-8 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| 1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate | 1,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate | 220410-74-2 | 429-370-5 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate | ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate | 122665-86-5 | 429-680-0 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| lithium sodium 4,4’, 4’’-(nitrilotris(ethane-2,1-diylimino (6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate | lithium sodium 4,4’, 4’’-(nitrilotris(ethane-2,1-diylimino (6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate | 193562-37-7 | 429-730-1 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| guanidinium benzoate | guanidinium benzoate | 26739-54-8 | 429-820-0 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate | methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate | 144550-06-1 | 429-890-2 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| (Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid | (Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid | 86978-24-7 | 430-100-3 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol | reaction mass of: calcium bis(C10-14 branched alkyl salicylate); calcium bis(C18-30-alkyl salicylate); calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate; calcium bis (C10-14 branched alkyl phenolate); calcium bis (C18-30-alkyl phenolate); calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate; C10-14 branched alkyl phenol; C18-30-alkyl phenol | 430-180-1 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | ||
| pentapotassium 2-(4-{]5-[}1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene{]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl[}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate | pentapotassium 2-(4-{]5-[}1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene{]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl[}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate | 430-210-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| ethyl (3R)-4-cyano-3-hydroxybutanoate | ethyl (3R)-4-cyano-3-hydroxybutanoate | 141942-85-0 | 430-220-6 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl) phenylazo)naphthalene-2-sulfonate | trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl) phenylazo)naphthalene-2-sulfonate | 430-280-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| methyl 3-amino-2,2,3-trimethylbutyrate | methyl 3-amino-2,2,3-trimethylbutyrate | 90886-53-6 | 431-720-7 | substance | Skin Corr. 1B; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H314; H302; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H314; H302; H412 | |
| reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate | reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid; ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate | 182176-52-9 | 432-190-1 | substance | Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1 | Hazard statement codes: H302; H373**; H318. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H302; H373**; H318 | |
| reaction mass of: succinic acid monopersuccinic acid dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic acid dimethyl adipate hydrogen peroxide methanol water | reaction mass of: succinic acid monopersuccinic acid dipersuccinic acid monomethyl ester of succinic acid monomethyl ester of persuccinic acid dimethyl succinate glutaric acid monoperglutaric acid diperglutaric acid monomethyl ester of glutaric acid monomethyl ester of perglutaric acid dimethyl glutarate adipic acid monoperadipic acid diperadipic acid monomethyl ester of adipic acid monomethyl ester of peradipic acid dimethyl adipate hydrogen peroxide methanol water | 432-790-1 | substance | Acute Tox. 4*; Acute Tox. 4*; Acute Tox. 4*; Skin Corr. 1B; STOT SE 2 | Hazard statement codes: H332; H312; H302; H314; H371 (eyes). Labelling pictogram and signal word: GHS07; GHS05; GHS08; Dgr. Labelling hazard statements: H332; H312; H302; H314; H371 (eyes) | ||
| 2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid | 2-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid | 63562-33-4 | 426-480-5 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance | reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance | 431-120-5 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H331; H302; H319; H317. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H331; H302; H319; H317 | ||
| 2,4-dichloro-5-fluorobenzoylchloride | 2,4-dichloro-5-fluorobenzoylchloride | 86393-34-2 | 428-390-1 | substance | STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H335; H315; H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H335; H315; H318; H317; H412 | |
| bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate | bis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate | 10138-36-0 | 430-700-5 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| menadione sodium bisulfite; 2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt | menadione sodium bisulfite; 2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt | 130-37-0 | 204-987-0 | substance | Eye Irrit. 2; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H319; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H315; H410 | |
| menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) | menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) | 73581-79-0 | 277-543-7 | substance | Eye Irrit. 2; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H319; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H315; H410 | |
| trisodium nitrilotriacetate | trisodium nitrilotriacetate | 5064-31-3 | 225-768-6 | substance | Carc. 2; Acute Tox. 4 *; Eye Irrit. 2 | Carc. 2; H351: | C ≥ 5 % | Hazard statement codes: H351; H302; H319. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H351; H302; H319 |
| milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] | milbemectin (ISO); [reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | M=100 | Hazard statement codes: H332; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H302; H410 | ||
| 2-ethylhexyl-2-ethylhexanoate | 2-ethylhexyl-2-ethylhexanoate | 7425-14-1 | 231-057-1 | substance | Repr. 2 | Hazard statement codes: H361d***. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H361d*** | |
| diisobutyl phthalate | diisobutyl phthalate | 84-69-5 | 201-553-2 | substance | Repr. 1B | Hazard statement codes: H360Df. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360Df’ | |
| perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] | perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] | 1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] | 217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] | substance | Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4 *; Acute Tox. 4 *; Lact.; Aquatic Chronic 2 | Hazard statement codes: H351; H360D***; H372**; H332; H302; H362; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H351; H360D***; H372**; H332; H302; H362; H411 | |
| clodinafop-propargyl (ISO | clodinafop-propargyl (ISO | 105512-06-9 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Skin Sens. 1; H317: C ≥ 0.001 % | M=1 | Hazard statement codes: H302; H373**; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373**; H317; H410 | |
| ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate | ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate | 103112-35-2 | 401-290-5 | substance | Carc. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H350; H410 | |
| [(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate | [(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate | 162221-28-5 | 416-360-0 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine | 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine | 171054-89-0 | 419-240-6 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid | [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid | 123599-82-6 | 419-270-1 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| acrylic acid, 3-(trimethoxysilyl)propyl ester | acrylic acid, 3-(trimethoxysilyl)propyl ester | 4369-14-6 | 419-560-6 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H332; H314; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H332; H314; H317; H412 | |
| reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate | reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate | 442-300-8 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide | N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide | 111244-14-5 | 420-210-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| trisodium 5-{][}4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl{]amino[}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate | trisodium 5-{][}4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl{]amino[}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate | 341026-59-3 | 440-480-2 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| (S)-(–)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate | (S)-(–)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate | 36394-75-9 | 420-610-4 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H302; H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314; H317 | |
| trisodium N-(3-propionato)-l-aspartate | trisodium N-(3-propionato)-l-aspartate | 172737-80-3 | 422-090-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 1-bromo-2-methylpropyl propionate | 1-bromo-2-methylpropyl propionate | 158894-67-8 | 422-900-6 | substance | Flam. Liq. 3; Carc. 2; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H226; H351; H314; H317. Labelling pictogram and signal word: GHS02; GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H226; H351; H314; H317 | |
| disodium 8-amino-5-{]4-[}2-(sulfonatoethoxy)sulfonyl{]phenylazo[} naphthalene-2-sulfonate | disodium 8-amino-5-{]4-[}2-(sulfonatoethoxy)sulfonyl{]phenylazo[} naphthalene-2-sulfonate | 250688-43-8 | 423-730-5 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 2-hydroxybenzoic acid 2-butyloctyl ester | 2-hydroxybenzoic acid 2-butyloctyl ester | 190085-41-7 | 431-090-3 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate | 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate | 216698-07-6 | 431-770-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid | 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid | 43028-69-9 | 431-930-9 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| 3,6,9-trithiaundecamethylene-1,11-dimethacrylate | 3,6,9-trithiaundecamethylene-1,11-dimethacrylate | 141631-22-3 | 432-210-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| dimethyl (2S)-2-hydroxysuccinate | dimethyl (2S)-2-hydroxysuccinate | 617-55-0 | 432-310-0 | substance | Flam. Liq. 3; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H226; H318; H317. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H318; H317 | |
| methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate | methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate | 81752-87-6 | 432-350-9 | substance | Skin Irrit. 2 | Hazard statement codes: H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315 | |
| tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl) ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo) naphthalene-1,7-disulfonate | tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl) ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo) naphthalene-1,7-disulfonate | 243858-01-7 | 432-550-6 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate | d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate | 124655-09-0 | 432-960-5 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane | 5-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane | 143446-73-5 | 433-530-1 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H302; H317; H400. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H400 | |
| [3-(chlorocarbonyl)-2-methylphenyl]acetate | [3-(chlorocarbonyl)-2-methylphenyl]acetate | 167678-46-8 | 433-690-0 | substance | Skin Corr. 1A; Skin Sens. 1 | Hazard statement codes: H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H314; H317 | |
| 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate | 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate | 145153-52-2 | 433-910-5 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| sodium 2-(nonanoyloxy)benzenesulfonate | sodium 2-(nonanoyloxy)benzenesulfonate | 91125-43-8 | 434-360-9 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| ethyl N2-dodecanoyl-l-argininate hydrochloride | ethyl N2-dodecanoyl-l-argininate hydrochloride | 60372-77-2 | 434-630-6 | substance | Eye Dam. 1; Aquatic Acute 1 | Hazard statement codes: H318; H400. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H400 | |
| tetrakis(bis(2-hydroxyethyl) methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino) -4-hydroxynaphthalene-2-sulfonate | tetrakis(bis(2-hydroxyethyl) methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino) -4-hydroxynaphthalene-2-sulfonate | 225786-91-4 | 434-840-8 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| (S)-3-hydroxy-γ-butyrolactone | (S)-3-hydroxy-γ-butyrolactone | 7331-52-4 | 434-990-4 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| ethyl 6,8-dichlorooctanoate | ethyl 6,8-dichlorooctanoate | 1070-64-0 | 435-080-1 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid | sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid | 141250-43-3 | 435-350-7 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | 172399-10-9 | 436-920-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt | 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt | 371921-63-0 | 440-770-9 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid | pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid | 321912-47-4 | 442-030-0 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 2-{]4-[}4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino{] phenylazophenylazo[}naphthalene-4,6,8-trisulfonate, trisodium salt | 2-{]4-[}4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino{] phenylazophenylazo[}naphthalene-4,6,8-trisulfonate, trisodium salt | 321679-52-1 | 442-230-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 1,1-dimethylethyl 4’-(bromomethyl)biphenyl-2-carboxylate | 1,1-dimethylethyl 4’-(bromomethyl)biphenyl-2-carboxylate | 114772-40-6 | 442-850-9 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| methyl 2-(acetylamino)-3-chloropropionate | methyl 2-(acetylamino)-3-chloropropionate | 87333-22-0 | 442-860-3 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate | bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate | 127474-91-3 | 442-980-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate | methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate | 393509-79-0 | 443-120-2 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | |
| trans-methyl-2-ethyl-but-2-enoate | trans-methyl-2-ethyl-but-2-enoate | 101226-85-1 | 443-150-6 | substance | Flam. Liq. 3 | Hazard statement codes: H226. Labelling pictogram and signal word: GHS02; Wng. Labelling hazard statements: H226 | |
| (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid | (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid | 88784-33-2 | 443-560-5 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| chloro-1-ethylcyclohexyl carbonate | chloro-1-ethylcyclohexyl carbonate | 99464-83-2 | 444-950-8 | substance | Muta. 2; Skin Sens. 1 | Hazard statement codes: H341; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H341; H317 | |
| trans-2-isopropyl-5-carboxy-1,3-dioxane | trans-2-isopropyl-5-carboxy-1,3-dioxane | 42031-28-7 | 445-770-2 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate | methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate | 376588-17-9 | 445-990-9 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate | dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate | 500791-70-8 | 448-700-9 | substance | STOT RE 2 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H373**; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H373**; H318; H317; H410 |
| diethyl 1,4-cyclohexanedicarboxylate | diethyl 1,4-cyclohexanedicarboxylate | 72903-27-6 | 417-310-0 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate | reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate | 419-000-0 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate | 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate | 419-570-0 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | ||
| reaction mass of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid | reaction mass of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid | 422-260-8 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | ||
| reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid | reaction mass of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid | 423-670-1 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| 2,5-dioxopyrrolidin-1-yl N-{][}methyl[[2-(1-methylethyl)-4-thiazolyl{]methylaminocarbonyl[}-l-valinate | 2,5-dioxopyrrolidin-1-yl N-{][}methyl[[2-(1-methylethyl)-4-thiazolyl{]methylaminocarbonyl[}-l-valinate | 424-660-8 | substance | STOT RE 2 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H373**; H318; H317. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H373**; H318; H317 | ||
| reaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate | reaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate | 427-090-8 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| reaction mass of: 3-{]5-[}3-(4-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(methyl)ammonium di(acetate); 3-{]5-[}4-(3-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido{]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate); 3-{]5-[}3-(4-{]1-[}3-(dimethylammonio)propyl{]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate) | reaction mass of: 3-{]5-[}3-(4-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(methyl)ammonium di(acetate); 3-{]5-[}4-(3-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido{]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate); 3-{]5-[}3-(4-{]1-[}3-(dimethylammonio)propyl{]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate) | 431-440-5 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | ||
| tert-butyl(6-{]2-[}4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino{] pyrimidin-5-ylvinyl[}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate | tert-butyl(6-{]2-[}4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino{] pyrimidin-5-ylvinyl[}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate | 432-810-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate | reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate | 432-910-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| complex reaction mass of Chinese gum rosin post reacted with acrylic acid | complex reaction mass of Chinese gum rosin post reacted with acrylic acid | 144413-22-9 | 434-230-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) | reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) | 435-450-0 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts | alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts | 243662-67-1 | 435-660-2 | substance | Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H317 | |
| ammonium 2-cocoyloxyethanesulfonate | ammonium 2-cocoyloxyethanesulfonate | 441-050-7 | substance | Skin Irrit. 2; Eye Dam. 1 | Hazard statement codes: H315; H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H315; H318 | ||
| 6,6’-bis(diazo-5,5’, 6,6’-tetrahydro-5,5’-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) | 6,6’-bis(diazo-5,5’, 6,6’-tetrahydro-5,5’-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) | 441-550-5 | substance | Self-react. C ****; Carc. 2 | Hazard statement codes: H242; H351. Labelling pictogram and signal word: GHS02; GHS08; Dgr. Labelling hazard statements: H242; H351 | ||
| reaction mass of: 2-{]3,6-bis-[}(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{]3,6-bis-[}(2,3-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{]3,6-bis-[}(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{]3,6-bis-[}(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %) | reaction mass of: 2-{]3,6-bis-[}(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{]3,6-bis-[}(2,3-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{]3,6-bis-[}(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{]3,6-bis-[}(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %); 2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %); 2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %) | 442-800-6 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | ||
| (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride | (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride | 444-320-2 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wn. Labelling hazard statements: H302 | ||
| reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans-isomers); methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers) | reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans-isomers); methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers) | 444-920-4 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| dimethyl[2S, 2S’]-6,6,6’6’-tetramethoxy-2,2’-[N,N’-bis(trifluoracetyl)-S, S’-bi (L-homocysteinyl) diimino]dihexanoate | dimethyl[2S, 2S’]-6,6,6’6’-tetramethoxy-2,2’-[N,N’-bis(trifluoracetyl)-S, S’-bi (L-homocysteinyl) diimino]dihexanoate | 255387-46-3 | 432-860-1 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | 448-690-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear | 446-470-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate | ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate | 163520-33-0 | 443-870-0 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| pentyl formate | pentyl formate | 638-49-3 | 211-340-6 | substance | Flam. Liq. 3; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H226; H319; H335. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H226; H319; H335. Notes: C | |
| tert-butyl propionate | tert-butyl propionate | 20487-40-5 | substance | Flam. Liq. 2 | Hazard statement codes: H225. Labelling pictogram and signal word: GHS02; Dgr. Labelling hazard statements: H225. Notes: C | ||
| 4-tert-butylbenzoic acid | 4-tert-butylbenzoic acid | 98-73-7 | 202-696-3 | substance | Repr. 1B; STOT RE 1; Acute Tox. 4 | Hazard statement codes: H360F; H372; H302. Labelling pictogram and signal word: GHS07; GHS08; Dgr. Labelling hazard statements: H360F; H372; H302 | |
| bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro- 3,3,3-trifluoroprop-1-en-1-yl]- 2,2-dimethylcyclopropanecarboxylate | bifenthrin (ISO); (2-methylbiphenyl-3-yl)methyl rel-(1R,3R)-3-[(1Z)-2-chloro- 3,3,3-trifluoroprop-1-en-1-yl]- 2,2-dimethylcyclopropanecarboxylate | 82657-04-3 | substance | Carc. 2; Acute Tox. 3; Acute Tox. 2; STOT RE 1; Skin Sens. 1B; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 000 | M = 100 000 | Hazard statement codes: H351; H331; H300; H372 (nervous system); H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H351; H331; H300; H372 (nervous system); H317; H410 | |
| indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5- dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine- 4a(3H)-carboxylate [2] | indoxacarb (ISO); methyl (4aS)-7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5- dihydroindeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylate [1] reaction mass of (S)- Indoxacarb and (R)- Indoxacarb 75:25; methyl 7-chloro-2-{(methoxycarbonyl)[4-(trifluoromethoxy)phenyl]carbamoyl}-2,5-dihydroindeno[1,2-e][1,3,4]oxadiazine- 4a(3H)-carboxylate [2] | 173584-44-6 [1] 144171-61-9 [2] | substance | Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H301; H332; H372 (blood, nervous system, heart); H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H332; H372 (blood, nervous system, heart); H317; H410 | |
| dihexyl phthalate | dihexyl phthalate | 84-75-3 | 201-559-5 | substance | Repr. 1B | Hazard statement codes: H360FD. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360FD | |
| ammoniumpentadeca- fluorooctanoate | ammoniumpentadeca- fluorooctanoate | 3825-26-1 | 223-320-4 | substance | Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; Acute Tox. 4; STOT RE 1; Eye Dam. 1 | Hazard statement codes: H351; H360D; H362; H332; H302; H372 (liver); H318. Labelling pictogram and signal word: GHS08; GHS07; GHS05; Dgr. Labelling hazard statements: H351; H360D; H362; H332; H302; H372 (liver); H318 | |
| perfluorooctanoic acid | perfluorooctanoic acid | 335-67-1 | 206-397-9 | substance | Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; Acute Tox. 4; STOT RE 1; Eye Dam. 1 | Hazard statement codes: H351; H360D; H362; H332; H302; H372 (liver); H318. Labelling pictogram and signal word: GHS08; GHS07; GHS05; Dgr. Labelling hazard statements: H351; H360D; H362; H332; H302; H372 (liver); H318 | |
| benzoic acid | benzoic acid | 65-85-0 | 200-618-2 | substance | STOT RE 1; Skin Irrit. 2; Eye Dam. 1 | Hazard statement codes: H372 (lungs) (inhalation); H315; H318. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H372 (lungs) (inhalation); H315; H318 | |
| methyl 2,5-dichlorobenzoate | methyl 2,5-dichlorobenzoate | 2905-69-3 | 220-815-7 | substance | Acute Tox. 4; STOT SE 3; Aquatic Chronic 2 | Hazard statement codes: H302; H336; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H336; H411 | |
| fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate | fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate | 71283-80-2 | substance | STOT RE 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H373 (kidneys); H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H373 (kidneys); H317; H410 | |
| octanoic acid | octanoic acid | 124-07-2 | 204-677-5 | substance | Skin Corr. 1C; Aquatic Chronic 3 | Hazard statement codes: H314; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314; H412 | |
| decanoic acid | decanoic acid | 334-48-5 | 206-376-4 | substance | Skin Irrit. 2; Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H315; H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H319; H412 | |
| 1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear | 1,2-benzenedicarboxylic acid, dihexyl ester, branched and linear | 68515-50-4 | 271-093-5 | substance | Repr. 1B | Hazard statement codes: H360FD. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360FD | |
| spirotetramat (ISO); (5s,8s)-3- (2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec- 3-en-4-yl ethyl carbonate | spirotetramat (ISO); (5s,8s)-3- (2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec- 3-en-4-yl ethyl carbonate | 203313-25-1 | substance | Repr. 2; STOT SE 3; Eye Irrit. 2; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H361fd; H335; H319; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361fd; H335; H319; H317; H410 | |
| dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin- 4-ium acetate | dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin- 4-ium acetate | 31717-87-0 | 250-778-2 | substance | Repr. 2; STOT RE 2; Skin Corr. 1C; Skin Sens. 1A; Aquatic Chronic 1 | M = 1 | Hazard statement codes: H361d; H373 (liver); H314; H317; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H361d; H373 (liver); H314; H317; H410. Supplementary hazard statements: EUH071 |
| fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate | fenpyroximate (ISO); tert-butyl 4-[({(E)-[(1,3-dimethyl-5-phenoxy-1H-pyrazol-4-yl)methylene]amino}oxy)methyl]benzoate | 134098-61-6 | substance | Acute Tox. 3; Acute Tox. 2; Skin Sens. 1B; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 1 000 | Hazard statement codes: H301; H330; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H330; H317; H410 | |
| triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6- (2,2,2-trifluoroethoxy)-1,3,5- triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate | triflusulfuron-methyl; methyl 2-({[4-(dimethylamino)-6- (2,2,2-trifluoroethoxy)-1,3,5- triazin-2-yl]carbamoyl}sulfamoyl)-3-methylbenzoate | 126535-15-7 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 10 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 | |
| bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate | bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate | 149877-41-8 | 442-820-5 | substance | STOT RE 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H373; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H373; H317; H410 |
| bromadiolone (ISO); 3- [3-(4′-bromobiphenyl- 4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy- 2H-chromen-2-one | bromadiolone (ISO); 3- [3-(4′-bromobiphenyl- 4-yl)-3-hydroxy-1-phenylpropyl]-4-hydroxy- 2H-chromen-2-one | 28772-56-7 | 249-205-9 | substance | Repr. 1B; Acute Tox. 1; Acute Tox. 1; Acute Tox. 1; STOT RE 1; Aquatic Acute 1; Aquatic Chronic 1 | Repr. 1B; H360D: | C ≥ 0.003 % | STOT RE 1; H372 (blood): C ≥ 0.005 % | STOT RE 2; H373 (blood): | 0.0005 % ≤ C < 0.005 % | M = 1 | M = 1 | Hazard statement codes: H360D; H330; H310; H300; H372 (blood); H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H360D; H330; H310; H300; H372 (blood); H410 |
| difethialone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]- 4-hydroxy-2H-1-benzothiopyran-2-one | difethialone (ISO); 3-[3-(4′-bromobiphenyl-4-yl)-1,2,3,4-tetrahydronaphthalen-1-yl]- 4-hydroxy-2H-1-benzothiopyran-2-one | 104653-34-1 | substance | Repr. 1B; Acute Tox. 1; Acute Tox. 1; Acute Tox. 1; STOT RE 1; Aquatic Acute 1; Aquatic Chronic 1 | Repr. 1B; H360D: | C ≥ 0.003 % | STOT RE 1; H372 (blood): C ≥ 0.02 % | STOT RE 2; H373 (blood): | 0.002 % ≤ C < 0.02 % | M = 100 | M = 100 | Hazard statement codes: H360D; H330; H310; H300; H372 (blood); H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H360D; H330; H310; H300; H372 (blood); H410. Supplementary hazard statements: EUH070 | |
| perfluorononan-1-oic acid [1] and its sodium [2] and ammonium [3] salts | perfluorononan-1-oic acid [1] and its sodium [2] and ammonium [3] salts | 375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3] | 206-801-3 [1] [2] [3] | substance | Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; Acute Tox. 4; STOT RE 1; Eye Dam. 1 | Hazard statement codes: H351; H360Df; H362; H332; H302; H372 (liver, thymus, spleen); H318. Labelling pictogram and signal word: GSH08; GSH07; GHS05; Dgr. Labelling hazard statements: H351; H360Df; H362; H332; H302; H372 (liver, thymus, spleen); H318 | |
| dicyclohexyl phthalate | dicyclohexyl phthalate | 84-61-7 | 201-545-9 | substance | Repr. 1B; Skin Sens. 1 | Hazard statement codes: H360D; H317. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360D; H317’ | |
| nonadecafluorodecanoic acid; [1] ammonium nonadecafluorodecanoate; [2] sodium nonadecafluorodecanoate [3] | nonadecafluorodecanoic acid; [1] ammonium nonadecafluorodecanoate; [2] sodium nonadecafluorodecanoate [3] | 335-76-2 [1] 3108-42-7 [2] 3830-45-3 [3] | 206-400-3 [1] 221-470-5 [2] - [3] | substance | Carc. 2; Repr. 1B; Lact. | Hazard statement codes: H351; H360Df; H362. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H351; H360Df; H362 | |
| N,N′-methylenedimorpholine; N,N′-methylenebismorpholine; [formaldehyde released from N,N′-methylenebismorpholine]; [MBM] | N,N′-methylenedimorpholine; N,N′-methylenebismorpholine; [formaldehyde released from N,N′-methylenebismorpholine]; [MBM] | 5625-90-1 | 227-062-3 | substance | Carc. 1B; Muta. 2; Acute Tox. 4; Acute Tox. 4; Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1; Eye Dam. 1 | Hazard statement codes: H350; H341; H332; H312; H302; H373 (gastrointestinal tract, respiratory tract); H314; H317; H318. Labelling pictogram and signal word: GHS08; GHS07; GHS05; Dgr. Labelling hazard statements: H350; H341; H332; H312; H302; H373 (gastrointestinal tract, respiratory tract); H314; H317. Supplementary hazard statements: EUH071. Notes: 8; 9 | |
| 2,3,5,6-tetrafluoro-4- (methoxymethyl)benzyl (Z)-(1R,3R)-3-(2-cyanoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; epsilon-momfluorothrin | 2,3,5,6-tetrafluoro-4- (methoxymethyl)benzyl (Z)-(1R,3R)-3-(2-cyanoprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; epsilon-momfluorothrin | 1065124-65-3 | substance | Acute Tox. 4; STOT SE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H302; H371 (nervous system); H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Wng. Labelling hazard statements: H302; H371 (nervous system) H410 | |
| tefluthrin (ISO); 2,3,5,6-tetrafluoro-4- methylbenzyl (1RS,3RS)- 3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropanecarboxylate | tefluthrin (ISO); 2,3,5,6-tetrafluoro-4- methylbenzyl (1RS,3RS)- 3-[(Z)-2-chloro-3,3,3-trifluoroprop-1-enyl]-2,2-dimethylcyclopropanecarboxylate | 79538-32-2 | substance | Acute Tox. 1; Acute Tox. 2; Acute Tox. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 000 | M = 10 000 | Hazard statement codes: H330; H310; H300; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H410 | |
| 2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (1R,3R)-2,2-dimethyl-3-[(1Z)-prop-1-en-1-yl] cyclopropanecarboxylate; epsilon-metofluthrin | 2,3,5,6-tetrafluoro-4-(methoxymethyl)benzyl (1R,3R)-2,2-dimethyl-3-[(1Z)-prop-1-en-1-yl] cyclopropanecarboxylate; epsilon-metofluthrin | 240494-71-7 | substance | Acute Tox. 4; Acute Tox. 3; STOT SE 1; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H332; H301; H370 (nervous system); H373; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H332; H301; H370 (nervous system) H373; H410 | |
| isopropyl (2E,4E,7S)-11-methoxy-3,7,11-trimethyldodeca- 2,4-dienoate; S-methoprene | isopropyl (2E,4E,7S)-11-methoxy-3,7,11-trimethyldodeca- 2,4-dienoate; S-methoprene | 65733-16-6 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)- 7-oxo-1,2,4,5-tetrahydro-7H- pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate | pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)- 7-oxo-1,2,4,5-tetrahydro-7H- pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate | 243973-20-8 | substance | Repr. 2; Acute Tox. 4; Acute Tox. 4; Eye Irrit. 2; STOT SE 3; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 3 | inhalation: | ATE = 4.63 mg/L | (dusts or mists) | oral: ATE = 500 mg/kg bw | M = 1 | Hazard statement codes: H361d; H332; H302; H319; H335; H317; H400; H412. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361d; H332; H302; H319; H335; H317; H410 | |
| tetramethrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop- 1-en-1-yl)cyclopropanecarboxylate | tetramethrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop- 1-en-1-yl)cyclopropanecarboxylate | 7696-12-0 | 231-711-6 | substance | Carc. 2; Acute Tox. 4; STOT SE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H351; H302; H371 (nervous system) (inhalation); H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H302; H371 (nervous system) (inhalation); H410 |
| (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylate | (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylate | 1166-46-7 | 214-619-0 | substance | Carc. 2; Acute Tox. 4; STOT SE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H351; H302; H371 (nervous system) (inhalation); H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H302; H371 (nervous system) (inhalation); H410 |
| mesosulfuron-methyl (ISO); methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-α-(methanesulfonamido)-p-toluate; | mesosulfuron-methyl (ISO); methyl 2-[(4,6-dimethoxypyrimidin-2-ylcarbamoyl)sulfamoyl]-α-(methanesulfonamido)-p-toluate; | 208465-21-8 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate | spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate | 148477-71-8 | substance | Carc. 1B; Repr. 2; STOT RE 2; Skin Sens. 1B; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H350; H361f; H373; H317; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H361f; H373; H317; H410 | |
| sodium methyl [(4-aminophenyl)sulphonyl]carbamate; sodium methyl (EZ)-sulfanilylcarbonimidate; asulam-sodium | sodium methyl [(4-aminophenyl)sulphonyl]carbamate; sodium methyl (EZ)-sulfanilylcarbonimidate; asulam-sodium | 2302-17-2 | 218-953-8 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 |
| salicylic acid | salicylic acid | 69-72-7 | 200-712-3 | substance | Repr. 2; Acute Tox. 4; Eye Dam. 1 | Hazard statement codes: H361d; H302; H318. Labelling pictogram and signal word: GHS08; GHS07; GHS05; Dgr. Labelling hazard statements: H361d; H302; H318’ | |
| cyflumetofen (ISO); 2-methoxyethyl (RS)-2- (4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate | cyflumetofen (ISO); 2-methoxyethyl (RS)-2- (4-tert-butylphenyl)-2-cyano-3-oxo-3-(α,α,α-trifluoro-o-tolyl)propionate | 400882-07-7 | substance | Carc. 2; Skin Sens. 1A | Hazard statement codes: H351; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H351; H317 | ||
| pentapotassium 2,2’,2’’,2’’’,2’’’’-(ethane-1,2- diylnitrilo)pentaacetate | pentapotassium 2,2’,2’’,2’’’,2’’’’-(ethane-1,2- diylnitrilo)pentaacetate | 7216-95-7 | 404-290-3 | substance | Acute Tox. 4; STOT RE 2; Eye Irrit. 2 | inhalation: ATE = 1.5 mg/l (dusts or mists) | Hazard statement codes: H332; H373 (inhalation); H319. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H332; H373 (inhalation); H319 |
| N-carboxymethyliminobis (ethylenenitrilo)tetra (acetic acid) | N-carboxymethyliminobis (ethylenenitrilo)tetra (acetic acid) | 67-43-6 | 200-652-8 | substance | Acute Tox. 4; STOT RE 2; Eye Irrit. 2 | inhalation: ATE = 1.5 mg/l (dusts or mists) | Hazard statement codes: H332; H373 (inhalation); H319. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H332; H373 (inhalation); H319 |
| pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate | pentasodium (carboxylatomethyl)iminobis(ethylenenitrilo)tetraacetate | 140-01-2 | 205-391-3 | substance | Acute Tox. 4; STOT RE 2 | inhalation: ATE = 1.5 mg/l (dusts or mists) | Hazard statement codes: H332; H373 (inhalation). Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H332; H373 (inhalation) |
| diisohexyl phthalate | diisohexyl phthalate | 71850-09-4 | 276-090-2 | substance | Repr. 1B | Hazard statement codes: H360FD. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360FD | |
| MCPA-thioethyl (ISO); S-ethyl (4-chloro-2- methylphenoxy)ethanethioate; S-ethyl 4- chloro-o-tolyloxythioacetate | MCPA-thioethyl (ISO); S-ethyl (4-chloro-2- methylphenoxy)ethanethioate; S-ethyl 4- chloro-o-tolyloxythioacetate | 25319- 90-8 | 246-831-4 | substance | Acute Tox. 4; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 450 mg/kg bw | M = 10 | M = 10 | Hazard statement codes: H302; H373 (liver); H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Wng. Labelling hazard statements: H302; H373 (liver); H410 |
| diisooctyl phthalate | diisooctyl phthalate | 27554- 26-3 | 248-523-5 | substance | Repr. 1B | Hazard statement codes: H360FD. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360FD | |
| 4-{[(6-chloropyridin- 3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one; flupyradifurone | 4-{[(6-chloropyridin- 3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one; flupyradifurone | 951659- 40-8 | substance | Acute Tox. 4; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 500 mg/kg bw | M = 10 | M = 10 | Hazard statement codes: H302; H373 (muscle); H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Wng. Labelling hazard statements: H302; H373 (muscle); H410 | |
| thiencarbazone-methyl (ISO); methyl 4-[(4,5-dihydro-3-methoxy-4- methyl-5-oxo-1H- 1,2,4-triazol-1-yl)carbonylsulfamoyl]-5- methylthiophene-3- carboxylate | thiencarbazone-methyl (ISO); methyl 4-[(4,5-dihydro-3-methoxy-4- methyl-5-oxo-1H- 1,2,4-triazol-1-yl)carbonylsulfamoyl]-5- methylthiophene-3- carboxylate | 317815- 83-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1000 | M = 1000 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| L-(+)-lactic acid; (2S)-2-hydroxypropanoic acid | L-(+)-lactic acid; (2S)-2-hydroxypropanoic acid | 79-33-4 | 201-196-2 | substance | Skin Corr. 1C; Eye Dam. 1 | Hazard statement codes: H314; H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314. Supplementary hazard statements: EUH071 | |
| 2-methoxyethyl acrylate | 2-methoxyethyl acrylate | 3121-61-7 | 221-499-3 | substance | Flam. Liq. 3; Muta. 2; Repr. 1B; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1C; Eye Dam. 1; Skin Sens. 1 | inhalation: ATE = 2.7 mg/L (vapours) | oral: ATE = 404 mg/kg bw | Hazard statement codes: H226; H341; H360FD; H331; H302; H314; H318; H317. Labelling pictogram and signal word: GHS02; GHS05; GHS06; GHS08; Dgr. Labelling hazard statements: H226; H341; H360FD; H331; H302; H314; H317. Supplementary hazard statements: EUH071 |
| glyoxylic acid …% | glyoxylic acid …% | 298-12-4 | 206-058-5 | substance | Eye Dam. 1; Skin Sens. 1B | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317. Notes: B | |
| sodium N-(hydroxymethyl)glycinate; [formaldehyde released from sodium N-(hydroxymethyl)glycinate] | sodium N-(hydroxymethyl)glycinate; [formaldehyde released from sodium N-(hydroxymethyl)glycinate] | 70161- 44-3 | 274-357-8 | substance | Carc. 1B; Muta. 2; Acute Tox. 4; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1 | inhalation: ATE = 3 mg/L (dusts or mists) | oral: ATE = 1100 mg/kg bw | Hazard statement codes: H350; H341; H332; H302; H335; H315; H319; H317. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H341; H332; H302; H335; H315; H319; H317. Notes: 8; 9 |
| 2,2-dibromo-2-cyanoacetamide; [DBNPA] | 2,2-dibromo-2-cyanoacetamide; [DBNPA] | 10222-01-2 | 233-539-7 | substance | Acute Tox. 2; Acute Tox. 3; STOT RE 1; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Inhalation: ATE = 0.24 mg/L (dusts/mists) | Oral: ATE = 118 mg/kg bw | M = 1 | M = 1 | Hazard statement codes: H330; H301; H372 (respiratory tract, inhalation); H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H330; H301; H372 (respiratory tract, inhalation); H315; H318; H317; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| [S-(Z,E)]-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoic acid; S-abscisic acid | [S-(Z,E)]-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoic acid; S-abscisic acid | 21293-29-8 | 244-319-5 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| methyl salicylate | methyl salicylate | 119-36-8 | 204-317-7 | substance | Repr. 2; Acute Tox. 4; Skin Sens. 1B | Oral: ATE = 890 mg/kg bw | Hazard statement codes: H361d; H302; H317. Labelling pictogram and signal word: GHS07; GHS08; Wng. Labelling hazard statements: H361d; H302; H317. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| citric acid | citric acid | 77-92-9 | 201-069-1 | substance | STOT SE 3; Eye Irrit. 2 | Hazard statement codes: H335; H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H335; H319. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| ethametsulfuron-methyl (ISO); methyl 2-({[4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)benzoate | ethametsulfuron-methyl (ISO); methyl 2-({[4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl]carbamoyl}sulfamoyl)benzoate | 97780-06-8 | substance | Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 1000 | M = 100 | Hazard statement codes: H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| trinexapac-ethyl (ISO); ethyl 4-[cyclopropyl(hydroxy)methylene]-3,5-dioxocyclohexanecarboxylate | trinexapac-ethyl (ISO); ethyl 4-[cyclopropyl(hydroxy)methylene]-3,5-dioxocyclohexanecarboxylate | 95266-40-3 | substance | Skin Sens. 1B; Aquatic Chronic 1 | M = 1 | Hazard statement codes: H317; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| (3aS,5S,6R,7aR,7bS,9aS,10R,12aS,12bS)-10-[(2S,3R,4R,5R)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-5,6-dihydroxy-7a,9a-dimethylhexadecahydro-3H-benzo[c]indeno[5,4-e]oxepin-3-one; 24-epibrassinolide | (3aS,5S,6R,7aR,7bS,9aS,10R,12aS,12bS)-10-[(2S,3R,4R,5R)-3,4-dihydroxy-5,6-dimethylheptan-2-yl]-5,6-dihydroxy-7a,9a-dimethylhexadecahydro-3H-benzo[c]indeno[5,4-e]oxepin-3-one; 24-epibrassinolide | 78821-43-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling hazard statements: H413. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | ||
| benzyl salicylate | benzyl salicylate | 118-58-1 | 204-262-9 | substance | Skin Sens. 1B | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| (RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate | (RS)-1-{1-ethyl-4-[4-mesyl-3-(2-methoxyethoxy)-o-toluoyl]pyrazol-5-yloxy}ethyl methyl carbonate; tolpyralate | 1101132-67-5 | substance | Carc. 2; Repr. 2; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 100 | Hazard statement codes: H351; H361d; H373 (eye); H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H361d; H373 (eye); H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acrylate; isobornyl acrylate | exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acrylate; isobornyl acrylate | 5888-33-5 | 227-561-6 | substance | Skin Sens. 1A | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| daminozide (ISO); 4-(2,2-dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid | daminozide (ISO); 4-(2,2-dimethylhydrazino)-4-oxobutanoic acid; N-dimethylaminosuccinamic acid | 1596-84-5 | 216-485-9 | substance | Carc. 2 | Hazard statement codes: H351. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H351. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| 4,4'-oxydi(benzenesulphonohydrazide) | 4,4'-oxydi(benzenesulphonohydrazide) | 80-51-3 | 201-286-1 | substance | Self-react. D; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H242; H400; H410. Labelling pictogram and signal word: GHS02; GHS09; Dgr. Labelling hazard statements: H242; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| toluene-4-sulphonohydrazide | toluene-4-sulphonohydrazide | 1576-35-8 | 216-407-3 | substance | Self-react. D | Hazard statement codes: H242. Labelling pictogram and signal word: GHS02; Dgr. Labelling hazard statements: H242. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| 2-[N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino]ethyl acetate; C.I. Disperse Blue 124 | 2-[N-ethyl-4-[(5-nitrothiazol-2-yl)azo]-m-toluidino]ethyl acetate; C.I. Disperse Blue 124 | 15141-18-1 | 239-203-6 | substance | Skin Sens. 1A | Skin Sens. 1A; H317: C ≥ 0.001% | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| Perfluoroheptanoic acid; tridecafluoroheptanoic acid | Perfluoroheptanoic acid; tridecafluoroheptanoic acid | 375-85-9 | 206-798-9 | substance | Repr. 1B; STOT RE 1 | Hazard statement codes: H360D; H372 (liver). Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D; H372 (liver). Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| methyl N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorophenyl)-β-alaninate; valifenalate | methyl N-(isopropoxycarbonyl)-L-valyl-(3RS)-3-(4-chlorophenyl)-β-alaninate; valifenalate | 283159-90-0 | substance | Carc. 2; Aquatic Chronic 2 | Hazard statement codes: H351; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H411. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | ||
| 6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid, sodium and tris(2-hydroxyethyl)ammonium salts | 6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid, sodium and tris(2-hydroxyethyl)ammonium salts | substance | Repr. 1B; Eye Irrit. 2 | Hazard statement codes: H360FD; H319. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360FD; H319. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |||
| 6-[(C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid | 6-[(C10-C13)-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid | 2156592-54-8 | substance | Repr. 1B; Eye Irrit. 2 | Hazard statement codes: H360FD; H319. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360FD; H319. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | ||
| 6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid | 6-[C12-18-alkyl-(branched, unsaturated)-2,5-dioxopyrrolidin-1-yl]hexanoic acid | substance | Repr. 1B | Hazard statement codes: H360FD. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360FD. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |||
| tetramethylene dimethacrylate | tetramethylene dimethacrylate | 2082-81-7 | 218-218-1 | substance | Skin Sens. 1B | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| 7,7,9(or 7,9,9)-trimethyl-4,13-dioxo-3,14-dioxa-5,12diazahexadecane-1,16-diyl bismethacrylate | 7,7,9(or 7,9,9)-trimethyl-4,13-dioxo-3,14-dioxa-5,12diazahexadecane-1,16-diyl bismethacrylate | 72869-86-4 | 276-957-5 | substance | Skin Sens. 1B | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| 2,2'-ethylenedioxydiethyl dimethacrylate | 2,2'-ethylenedioxydiethyl dimethacrylate | 109-16-0 | 203-652-6 | substance | Skin Sens. 1B | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| bifenox (ISO); methyl 5-(2,4-dichlorophenoxy)-2-nitrobenzoate | bifenox (ISO); methyl 5-(2,4-dichlorophenoxy)-2-nitrobenzoate | 42576-02-3 | 255-894-7 | substance | Acute Tox. 4; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 1500 mg/kg bw | M = 1 000 | M = 1 000 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| 2,3-epoxypropyl neodecanoate | 2,3-epoxypropyl neodecanoate | 26761-45-5 | 247-979-2 | substance | Skin Sens. 1A; Muta. 2 | Skin Sens. 1A;H317: C ≥ 0.001% | Hazard statement codes: H317; H341. Labelling pictogram and signal word: GHS07; GHS08; Wng. Labelling hazard statements: H317; H341. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| benthiavalicarb_x0002_isopropyl (ISO); isopropyl [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamate | benthiavalicarb_x0002_isopropyl (ISO); isopropyl [(S)-1-{[(R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]carbamoyl}-2-methylpropyl]carbamate | 177406-68-7 | substance | Carc. 1B; Repr. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H350; H361d; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H361d; H317; H411. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | ||
| hexyl salicylate | hexyl salicylate | 6259-76-3 | 228-408-6 | substance | Skin Sens. 1; Repr. 2 | Hazard statement codes: H317; H361d. Labelling pictogram and signal word: GHS07; GHS08; Wng. Labelling hazard statements: H317; H361d. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| 7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate | 7-oxabicyclo[4.1.0]hept-3-ylmethyl 7-oxabicyclo[4.1.0]heptane-3-carboxylate | 2386-87-0 | 219-207-4 | substance | Skin Sens. 1; Muta. 2; STOT RE 2 | Hazard statement codes: H317; H341; H373 (nasal cavity). Labelling pictogram and signal word: GHS07; GHS08; Wng. Labelling hazard statements: H317; H341; H373 (nasal cavity). Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| tetrasodium 4-amino-5- hydroxy-3,6-bis[[4-[[2- (sulphonatooxy) ethyl]sulphonyl]phenyl]azo]n aphthalene-2,7-disulphonate; [1] Reaction products of 4- amino-5- hydroxynaphthalene-2,7- disulfonic acid, coupled twice with diazotized 2-[(4- aminophenyl)sulfonyl]ethyl hydrogen sulfate, sodium salts; [2] disodium 4-amino-5-hydroxy_x0002_3,6-bis{[4-(vinylsulfonyl) phenyl]diazenyl}naphthalene_x0002_2,7-disulfonate; [3] | tetrasodium 4-amino-5- hydroxy-3,6-bis[[4-[[2- (sulphonatooxy) ethyl]sulphonyl]phenyl]azo]n aphthalene-2,7-disulphonate; [1] Reaction products of 4- amino-5- hydroxynaphthalene-2,7- disulfonic acid, coupled twice with diazotized 2-[(4- aminophenyl)sulfonyl]ethyl hydrogen sulfate, sodium salts; [2] disodium 4-amino-5-hydroxy_x0002_3,6-bis{[4-(vinylsulfonyl) phenyl]diazenyl}naphthalene_x0002_2,7-disulfonate; [3] | 17095-24-8 [1] - [2] 100556-82-9 [3] | 241-164-5 [1] - [2] - [3] | substance | Resp. Sens. 1A; Skin Sens. 1 | Hazard statement codes: H334; H317. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334; H317. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| Sodium 3-(allyloxy)-2-hydroxypropanesulphonate | Sodium 3-(allyloxy)-2-hydroxypropanesulphonate | 52556 -42-0 | 258- 004-5 | substance | Repr. 1B; Eye Dam. 1 | Hazard statement codes: H360F; H318. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H360F; H318. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| 2-ethylhexanoic acid, monoester with propane-1,2-diol | 2-ethylhexanoic acid, monoester with propane-1,2-diol | 85114-0_x0002_0-7 | 285-503-5 | substance | Repr. 1B | Hazard statement codes: H360D. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| acetonitrile; cyanomethane | acetonitrile; cyanomethane | 75-05-8 | 200-835-2 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H225; H332; H312; H302; H319. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H332; H312; H302; H319 | |
| trichloroacetonitrile | trichloroacetonitrile | 545-06-2 | 208-885-7 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Chronic 2 | Hazard statement codes: H331; H311; H301; H411. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H411 | |
| acrylonitrile | acrylonitrile | 107-13-1 | 203-466-5 | substance | Flam. Liq. 2; Carc. 1B; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | * | Hazard statement codes: H225; H350; H331; H311; H301; H335; H315; H318; H317; H411. Labelling pictogram and signal word: GHS02; GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H225; H350; H331; H311; H301; H335; H315; H318; H317; H411. Notes: D |
| 2-hydroxy-2-methylpropionitrile; 2-cyanopropan-2-ol; acetone cyanohydrin | 2-hydroxy-2-methylpropionitrile; 2-cyanopropan-2-ol; acetone cyanohydrin | 75-86-5 | 200-909-4 | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H310; H300; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H410 | |
| n-butyronitrile | n-butyronitrile | 109-74-0 | 203-700-6 | substance | Flam. Liq. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 * | Hazard statement codes: H225; H331; H311; H301. Labelling pictogram and signal word: GHS02; GHS06; Dgr. Labelling hazard statements: H225; H331; H311; H301 | |
| bromoxynil (ISO) 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol | bromoxynil (ISO) 3,5-dibromo-4-hydroxybenzonitrile; bromoxynil phenol | 1689-84-5 | 216-882-7 | substance | Repr. 2; Acute Tox. 2 *; Acute Tox. 3 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H361d ***; H330; H301; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H361d ***; H330; H301; H317; H410 |
| ioxynil (ISO) 4-hydroxy-3,5-diiodobenzonitrile | ioxynil (ISO) 4-hydroxy-3,5-diiodobenzonitrile | 1689-83-4 | 216-881-1 | substance | Repr. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 2 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H361d ***; H331; H301; H312; H373 **; H319; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H361d ***; H331; H301; H312; H373 **; H319; H410 |
| chloroacetonitrile | chloroacetonitrile | 107-14-2 | 203-467-0 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Chronic 2 | Hazard statement codes: H331; H311; H301; H411. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H411 | |
| malononitrile | malononitrile | 109-77-3 | 203-703-2 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H410 | |
| methacrylonitrile; 2-methyl-2-propene nitrile | methacrylonitrile; 2-methyl-2-propene nitrile | 126-98-7 | 204-817-5 | substance | Flam. Liq. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Skin Sens. 1 | * | Skin Sens. 1; | H317: C ≥ 0.2 % | Hazard statement codes: H225; H331; H311; H301; H317. Labelling pictogram and signal word: GHS02; GHS06; Dgr. Labelling hazard statements: H225; H331; H311; H301; H317. Notes: D |
| oxalonitrile; cyanogen | oxalonitrile; cyanogen | 460-19-5 | 207-306-5 | substance | Press. Gas; Flam. Gas 1; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H220; H331; H400; H410. Labelling pictogram and signal word: GHS02; GHS04; GHS06; GHS09; Dgr. Labelling hazard statements: H220; H331; H410. Notes: U | |
| benzonitrile | benzonitrile | 100-47-0 | 202-855-7 | substance | Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302 | |
| 2-chlorobenzonitrile | 2-chlorobenzonitrile | 873-32-5 | 212-836-5 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H312; H302; H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302; H319 | |
| chlorothalonil (ISO); tetrachloroisophthalonitrile | chlorothalonil (ISO); tetrachloroisophthalonitrile | 1897-45-6 | 217-588-1 | substance | Carc. 2; Acute Tox. 2 *; STOT SE 3; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H351; H330; H335; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H351; H330; H335; H318; H317; H400; H410 |
| dichlobenil (ISO); 2,6-dichlorobenzonitrile | dichlobenil (ISO); 2,6-dichlorobenzonitrile | 1194-65-6 | 214-787-5 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H312; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H411 | |
| 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene | 1,4-Dicyano-2,3,5,6-tetra-chloro-benzene | 1897-41-2 | 401-550-8 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate | bromoxynil octanoate (ISO); 2,6-dibromo-4-cyanophenyl octanoate | 1689-99-2 | 216-885-3 | substance | Repr. 2; Acute Tox. 3 *; Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H361d ***; H331; H302; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H361d ***; H331; H302; H317; H410 |
| ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate | ioxynil octanoate (ISO); 4-cyano-2,6-diiodophenyl octanoate | 3861-47-0 | 223-375-4 | substance | Repr. 2; Acute Tox. 3 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H361d ***; H301; H319; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H361d ***; H301; H319; H317; H410 |
| 2,2'-dimethyl-2,2'-azodipropiononitrile; ADZN | 2,2'-dimethyl-2,2'-azodipropiononitrile; ADZN | 78-67-1 | 201-132-3 | substance | Self-react. C; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H242; H332; H302; H412. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H242; H332; H302; H412. Notes: T | |
| diphenoxymethylenecyanamide | diphenoxymethylenecyanamide | 79463-77-7 | 427-300-8 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile | 3-(2-(diaminomethyleneamino)thiazol-4-ylmethylthio)propionitrile | 76823-93-3 | 403-710-2 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| 3,7-dimethyloctanenitrile | 3,7-dimethyloctanenitrile | 40188-41-8 | 403-620-3 | substance | Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H315; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H317; H411 | |
| fenbuconazole (ISO); 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile | fenbuconazole (ISO); 4-(4-chlorophenyl)-2-phenyl-2-[(1H-1,2,4-triazol-1-yl)methyl]butanenitrile | 114369-43-6 | 406-140-2 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 2-(4-(N-butyl-N-phenethylamino)phenyl) ethylene-1,1,2-tricarbonitrile | 2-(4-(N-butyl-N-phenethylamino)phenyl) ethylene-1,1,2-tricarbonitrile | 97460-76-9 | 407-650-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile | 2-nitro-4,5-bis(benzyloxy)phenylacetonitrile | 117568-27-1 | 410-970-0 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 3-cyano-3,5,5-trimethylcyclohexanone | 3-cyano-3,5,5-trimethylcyclohexanone | 7027-11-4 | 411-490-4 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H373 **; H317; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H302; H373 **; H317; H412 | |
| reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(2-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(3-ethylphenyl)-2,2-dimethylpropanenitrile | reaction mass of: 3-(4-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(2-ethylphenyl)-2,2-dimethylpropanenitrile; 3-(3-ethylphenyl)-2,2-dimethylpropanenitrile | 412-660-0 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| 4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate | 4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate | 147374-67-2 | 413-510-7 | substance | STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H373 **; H317; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373 **; H317; H411 | |
| 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile | 1,2-dihydro-6-hydroxy-4-methyl-1-[3-(1-methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile | 68612-94-2 | 411-990-2 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide | N-acetyl-N-[5-cyano-3-(2-dibutylamino-4-phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo-1,2,3,6-tetrahydropyridin-1-yl]benzamide | 147741-93-3 | 412-340-0 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 2-benzyl-2-methyl-3-butenitrile | 2-benzyl-2-methyl-3-butenitrile | 97384-48-0 | 407-870-4 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl) methyl]-N’-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine | acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl) methyl]-N’-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine | 135410-20-7; 160430-64-8 | substance | Acute Tox. 3; Repr. 2; Aquatic Acute 1; Aquatic Chronic 1 | Oral: | ATE = 140 mg/kg bw | M = 10 | M = 10 | Hazard statement codes: H301; H361d; H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H301; H361d; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide | N-butyl-3-(2-chloro-4-nitrophenylhydrazono)-1-cyano-2-methylprop-1-ene-1,3-dicarboximide | 75511-91-0 | 407-970-8 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile | chlorfenapyr (ISO); 4-bromo-2-(4-chlorophenyl)-1-ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile | 122453-73-0 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | M=100 | Hazard statement codes: H331; H302; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H302; H410 | |
| (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile | (±)-α-[(2-acetyl-5-methylphenyl)-amino]-2,6-dichlorobenzene-aceto-nitrile | 419-290-9 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | ||
| 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl} vinyl)benzonitrile | 3-(2-{4-[2-(4-cyanophenyl)vinyl]phenyl} vinyl)benzonitrile | 79026-02-1 | 419-060-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: (E)-2,12-tridecadiennitrile; (E)-3,12-tridecadiennitrile; (Z)-3,12-tridecadiennitrile | reaction mass of: (E)-2,12-tridecadiennitrile; (E)-3,12-tridecadiennitrile; (Z)-3,12-tridecadiennitrile | 422-190-8 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| 2,2,4-trimethyl-4-phenyl-butane-nitrile | 2,2,4-trimethyl-4-phenyl-butane-nitrile | 75490-39-0 | 422-580-8 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| 2-phenylhexanenitrile | 2-phenylhexanenitrile | 3508-98-3 | 423-460-8 | substance | Acute Tox. 4; Aquatic Chronic 2 | oral: ATE = 500 mg/kg bw | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 |
| 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) | 4,4'-dithiobis(5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile) | 130755-46-3 | 423-490-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non- 1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile | 4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non- 1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrile | 138401-24-8 | 423-500-4 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide | (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide | 194602-27-2 | 421-810-4 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H317; H411 | |
| 3-(cis-3-hexenyloxy)propanenitril | 3-(cis-3-hexenyloxy)propanenitril | 142653-61-0 | 415-220-6 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H302; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H302; H410 | |
| 2-cyclohexylidene-2-phenylacetonitrile | 2-cyclohexylidene-2-phenylacetonitrile | 10461-98-0 | 423-740-1 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| 5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile | 5-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile | 77889-90-8 | 425-310-7 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2-piperidin-1-yl-benzonitrile | 2-piperidin-1-yl-benzonitrile | 72752-52-4 | 427-330-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile | 1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile | 152630-47-2 | 427-450-4 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H373**; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373**; H317; H411 | |
| 2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile | 2-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile | 157362-53-3 | 429-180-2 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile; 5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile | reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile; 5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile | 429-760-5 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| (R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | (R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 219861-18-4 | 430-760-2 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| (S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | (S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 128173-52-4 | 430-770-7 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile | 103146-25-4 | 430-780-1 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate | (R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate | 430-790-6 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H317; H411 | ||
| fipronil (ISO); (±)-5-amino-1-(2,6-dichloro-α,α,α-trifluoro- para-tolyl)-4-trifluoromethylsulfinyl-pyrazole-3- carbonitrile | fipronil (ISO); (±)-5-amino-1-(2,6-dichloro-α,α,α-trifluoro- para-tolyl)-4-trifluoromethylsulfinyl-pyrazole-3- carbonitrile | 120068-37-3 | 424-610-5 | substance | Acute Tox. 3*; Acute Tox. 3*; Acute Tox. 3*; STOT RE 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 000 | M = 10 000 | Hazard statement codes: H301; H311; H331; H372*; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H301; H311; H331; H372*; H410 |
| N-methyl-N-cyanomethylmorpholiniummethylsulfate | N-methyl-N-cyanomethylmorpholiniummethylsulfate | 429-340-1 | substance | Acute Tox. 4 *; Eye Dam. 1 | Hazard statement codes: H302; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318 | ||
| 4-(cyanomethyl)-4-methylmorpholin-4- ium hydrogen sulfate | 4-(cyanomethyl)-4-methylmorpholin-4- ium hydrogen sulfate | 208538-34-5 | 431-200-1 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H317 | |
| esfenvalerate (ISO); (S)-α-cyano- 3-phenoxybenzyl-(S)- 2-(4-chlorophenyl)- 3-methylbutyrate | esfenvalerate (ISO); (S)-α-cyano- 3-phenoxybenzyl-(S)- 2-(4-chlorophenyl)- 3-methylbutyrate | 66230-04-4 | substance | Acute Tox. 2; Acute Tox. 3; STOT RE 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Inhalation: ATE = 0.48 mg/L (dusts/mists) | Oral: ATE = 88.5 mg/kg bw | M = 10000 | M = 10000 | Hazard statement codes: H330; H301; H373; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H301; H373; H317; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile | 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile | 120068-79-3 | 421-240-6 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile | 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile | 138564-59-7 | 421-300-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 2-fluoro-4-hydroxybenzonitrile | 2-fluoro-4-hydroxybenzonitrile | 82380-18-5 | 422-810-7 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H411 | |
| (S)-α-hydroxy-3-phenoxy-benzeneacetonitrile | (S)-α-hydroxy-3-phenoxy-benzeneacetonitrile | 61826-76-4 | 441-070-6 | substance | Acute Tox. 3 *; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H301; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H301; H318; H317; H410 | |
| cyanomethyltrimethylammoniummethylsulfate | cyanomethyltrimethylammoniummethylsulfate | 433-720-2 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| salts of bromoxynil with the exception of those specified elsewhere in this Annex | salts of bromoxynil with the exception of those specified elsewhere in this Annex | substance | Repr. 2; Acute Tox. 2 *; Acute Tox. 3 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H361d ***; H330; H301; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H361d ***; H330; H301; H317; H410. Notes: A | ||
| salts of ioxynil with the exception of those specified elsewhere in this Annex | salts of ioxynil with the exception of those specified elsewhere in this Annex | substance | Repr. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 2 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H361d ***; H331; H301; H312; H373 **; H319; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H361d ***; H331; H301; H312; H373 **; H319; H410. Notes: A | ||
| 3,7-dimethylocta-2,6- dienenitrile | 3,7-dimethylocta-2,6- dienenitrile | 5146-66-7 | 225-918-0 | substance | Muta. 1B | Hazard statement codes: H340. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H340 | |
| flutianil (ISO); (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2- ylidene]acetonitrile | flutianil (ISO); (2Z)-{[2-fluoro-5-(trifluoromethyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2- ylidene]acetonitrile | 958647-10-4 | substance | Aquatic Chronic 1 | M = 100 | Hazard statement codes: H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| fludioxonil (ISO); 4-(2,2- difluoro-1,3-benzodioxol- 4-yl)-1H-pyrrole-3-carbonitrile | fludioxonil (ISO); 4-(2,2- difluoro-1,3-benzodioxol- 4-yl)-1H-pyrrole-3-carbonitrile | 131341-86-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 10 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 1-nitropropane | 1-nitropropane | 108-03-2 | 203-544-9 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | * | Hazard statement codes: H226; H332; H312; H302. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H332; H312; H302 |
| 2-nitropropane | 2-nitropropane | 79-46-9 | 201-209-1 | substance | Flam. Liq. 3; Carc. 1B; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H226; H350; H332; H302. Labelling pictogram and signal word: GHS02; GHS08; GHS07; Dgr. Labelling hazard statements: H226; H350; H332; H302 | |
| nitrobenzene | nitrobenzene | 98-95-3 | 202-716-0 | substance | Carc. 2; Repr. 1B; Acute Tox. 3; Acute Tox. 3; Acute Tox. 3; STOT RE 1; Aquatic Chronic 3 | Hazard statement codes: H351; H360F; H301; H311; H331; H372 (blood); H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H351; H360F; H301; H311; H331; H372 (blood); H412 | |
| dinitrobenzene; [1] 1,4-dinitrobenzene; [2] 1,3-dinitrobenzene; [3] 1,2-dinitrobenzene [4] | dinitrobenzene; [1] 1,4-dinitrobenzene; [2] 1,3-dinitrobenzene; [3] 1,2-dinitrobenzene [4] | 25154-54-5 [1] 100-25-4 [2] 99-65-0 [3] 528-29-0 [4] | 246-673-6 [1] 202-833-7 [2] 202-776-8 [3] 208-431-8 [4] | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H310; H300; H373 **; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H373 **; H410 | |
| 1,3,5-trinitrobenzene | 1,3,5-trinitrobenzene | 99-35-4 | 202-752-7 | substance | Expl. 1.1; Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H201; H330; H310; H300; H373**; H400; H410. Labelling pictogram and signal word: GHS01; GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H201; H330; H310; H300; H373**; H410 | |
| 4-nitrotoluene | 4-nitrotoluene | 99-99-0 | 202-808-0 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H331; H311; H301; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H411 | |
| 2,4-dinitrotoluene; [1] dinitrotoluene [2] | 2,4-dinitrotoluene; [1] dinitrotoluene [2] | 121-14-2 [1] 25321-14-6 [2] | 204-450-0 [1] 246-836-1 [2] | substance | Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H341; H361f***; H331; H311; H301; H373**; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H341; H361f***; H331; H311; H301; H373**; H410 | |
| 2,4,6-trinitrotoluene; TNT | 2,4,6-trinitrotoluene; TNT | 118-96-7 | 204-289-6 | substance | Expl. 1.1; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H201; H331; H311; H301; H373 **; H411. Labelling pictogram and signal word: GHS01; GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H201; H331; H311; H301; H373 **; H411 | |
| 2,4,6-trinitrophenol; picric acid | 2,4,6-trinitrophenol; picric acid | 88-89-1 | 201-865-9 | substance | Expl. 1.1; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 * | Hazard statement codes: H201; H331; H311; H301. Labelling pictogram and signal word: GHS01; GHS06; Dgr. Labelling hazard statements: H201; H331; H311; H301 | |
| salts of picric acid | salts of picric acid | substance | Unst. Expl.; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 * | Hazard statement codes: H201; H331; H311; H301. Labelling pictogram and signal word: GHS01; GHS06; Dgr. Labelling hazard statements: H201; H331; H311; H301. Notes: T | |||
| 2,4,6-trinitroanisole | 2,4,6-trinitroanisole | 606-35-9 | substance | Expl. 1.1; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H201; H332; H312; H302; H411. Labelling pictogram and signal word: GHS01; GHS07; GHS09; Wng. Labelling hazard statements: H201; H332; H312; H302; H411 | ||
| 2,4,6-trinitro-m-cresol | 2,4,6-trinitro-m-cresol | 602-99-3 | 210-027-1 | substance | Expl. 1.1; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H201; H332; H312; H302. Labelling pictogram and signal word: GHS01; GHS07; Wng. Labelling hazard statements: H201; H332; H312; H302 | |
| 2,4,6-trinitro-m-xylene | 2,4,6-trinitro-m-xylene | 632-92-8 | 211-187-5 | substance | Expl. 1.1; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 * | Hazard statement codes: H201; H332; H312; H302; H373 **. Labelling pictogram and signal word: GHS01; GHS08; GHS07; Wng. Labelling hazard statements: H201; H332; H312; H302; H373 ** | |
| 4-nitrophenol; p-nitrophenol | 4-nitrophenol; p-nitrophenol | 100-02-7 | 202-811-7 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 * | Hazard statement codes: H332; H312; H302; H373 **. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H332; H312; H302; H373 ** | |
| dinitrophenol (reaction mass of isomers); [1] 2,4(or 2,6)-dinitrophenol [2] | dinitrophenol (reaction mass of isomers); [1] 2,4(or 2,6)-dinitrophenol [2] | 25550-58-7 [1] 71629-74-8 [2] | 247-096-2 [1] 275-732-9 [2] | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H373 **; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H410 | |
| 2,4,6-trinitroresorcinol; styphnic acid | 2,4,6-trinitroresorcinol; styphnic acid | 82-71-3 | 201-436-6 | substance | Expl. 1.1; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H201; H332; H312; H302. Labelling pictogram and signal word: GHS01; GHS07; Wng. Labelling hazard statements: H201; H332; H312; H302. Notes: T | |
| lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate | lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate | 15245-44-0 | 239-290-0 | substance | Unst. Expl.; Repr. 1A; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H200; H360Df; H332; H302; H373 **; H400; H410. Labelling pictogram and signal word: GHS01; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H200; H360Df; H332; H302; H373 **; H410. Notes: 1 | |
| lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate (≥ 20 % phlegmatiser) | lead 2,4,6-trinitro-m-phenylene dioxide; lead 2,4,6-trinitroresorcinoxide; lead styphnate (≥ 20 % phlegmatiser) | 15245-44-0 | 239-290-0 | substance | Expl. 1.1; Repr. 1A; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H201; H360Df; H332; H302; H373 **; H400; H410. Labelling pictogram and signal word: GHS01; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H201; H360Df; H332; H302; H373 **; H410. Notes: 1 | |
| DNOC (ISO); 4,6-dinitro-o-cresol | DNOC (ISO); 4,6-dinitro-o-cresol | 534-52-1 | 208-601-1 | substance | Muta. 2; Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H341; H330; H310; H300; H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H341; H330; H310; H300; H315; H318; H317; H410. Supplementary hazard statements: EUH044 | |
| sodium salt of DNOC; sodium 4,6-dinitro-o-cresolate; [1] potassium salt of DNOC; potassium 4,6-dinitro-o-cresolate [2] | sodium salt of DNOC; sodium 4,6-dinitro-o-cresolate; [1] potassium salt of DNOC; potassium 4,6-dinitro-o-cresolate [2] | 2312-76-7 [1] 5787-96-2 [2] | 219-007-7 [1] - [2] | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H373 **; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H410 | |
| ammonium salt of DNOC; ammonium 4,6-dinitro-o-tolyl oxide | ammonium salt of DNOC; ammonium 4,6-dinitro-o-tolyl oxide | 2980-64-5 | 221-037-0 | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H310; H300; H373 **; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H373 **; H410 | |
| dinocap (ISO); (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which ‘octyl’ is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups | dinocap (ISO); (RS)-2,6-dinitro-4-octylphenyl crotonates and (RS)-2,4-dinitro-6-octylphenyl crotonates in which ‘octyl’ is a reaction mass of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl groups | 39300-45-3 | 254-408-0 | substance | Repr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=100 | Hazard statement codes: H360D***; H332; H302; H373**; H315; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H360D***; H332; H302; H373**; H315; H317; H410 |
| binapacryl (ISO); 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate | binapacryl (ISO); 2-sec-butyl-4,6-dinitrophenyl-3-methylcrotonate | 485-31-4 | 207-612-9 | substance | Repr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360D ***; H312; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H360D ***; H312; H302; H410 | |
| dinoseb(ISO); 6-sec-butyl-2,4-dinitrophenol | dinoseb(ISO); 6-sec-butyl-2,4-dinitrophenol | 88-85-7 | 201-861-7 | substance | Repr. 1B; Acute Tox. 3 *; Acute Tox. 3 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360Df; H311; H301; H319; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H360Df; H311; H301; H319; H410. Supplementary hazard statements: EUH044 | |
| salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex | salts and esters of dinoseb, with the exception of those specified elsewhere in this Annex | substance | Repr. 1B; Acute Tox. 3 *; Acute Tox. 3 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360Df; H311; H301; H319; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H360Df; H311; H301; H319; H410. Supplementary hazard statements: EUH044. Notes: A | |||
| dinocton; reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate | dinocton; reaction mass of isomers: methyl 2-octyl-4,6-dinitrophenyl carbonate, methyl 4-octyl-2,6-dinitrophenyl carbonate | 63919-26-6 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | ||
| dinex (ISO); 2-cyclohexyl-4,6-dinitrophenol | dinex (ISO); 2-cyclohexyl-4,6-dinitrophenol | 131-89-5 | 205-042-5 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H410 | |
| salts and esters of dinex | salts and esters of dinex | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H410. Notes: A | |||
| dinoterb (ISO); 2-tert-butyl-4,6-dinitrophenol | dinoterb (ISO); 2-tert-butyl-4,6-dinitrophenol | 1420-07-1 | 215-813-8 | substance | Repr. 1B; Acute Tox. 2 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360D ***; H300; H311; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H360D ***; H300; H311; H410. Supplementary hazard statements: EUH044 | |
| salts and esters of dinoterb | salts and esters of dinoterb | substance | Repr. 1B; Acute Tox. 2 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360D ***; H300; H311; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H360D ***; H300; H311; H410. Notes: A | |||
| bromofenoxim (ISO); 3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime | bromofenoxim (ISO); 3,5-dibromo-4-hydroxybenzaldehyde-O-(2,4-dinitrophenyl)-oxime | 13181-17-4 | 236-129-6 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrophenol | dinosam (ISO); 2-(1-methylbutyl)-4,6-dinitrophenol | 4097-36-3 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H410 | ||
| salts and esters of dinosam | salts and esters of dinosam | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H311; H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H410. Notes: A | |||
| nitroethane | nitroethane | 79-24-3 | 201-188-9 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 * | * | Hazard statement codes: H226; H332; H302. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H332; H302 |
| nitromethane | nitromethane | 75-52-5 | 200-876-6 | substance | Flam. Liq. 3; Acute Tox. 4 * | * | Hazard statement codes: H226; H302. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H302 |
| 5-nitroacenaphthene | 5-nitroacenaphthene | 602-87-9 | 210-025-0 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350 | |
| 2-nitronaphthalene | 2-nitronaphthalene | 581-89-5 | 209-474-5 | substance | Carc. 1B; Aquatic Chronic 2 | Hazard statement codes: H350; H411. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H350; H411 | |
| 4-nitrobiphenyl | 4-nitrobiphenyl | 92-93-3 | 202-204-7 | substance | Carc. 1B; Aquatic Chronic 2 | Hazard statement codes: H350; H411. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H350; H411 | |
| nitrofen (ISO); 2,4-dichlorophenyl 4-nitrophenyl ether | nitrofen (ISO); 2,4-dichlorophenyl 4-nitrophenyl ether | 1836-75-5 | 217-406-0 | substance | Carc. 1B; Repr. 1B; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H360D ***; H302; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H350; H360D ***; H302; H410 | |
| 2,4-dinitrophenol | 2,4-dinitrophenol | 51-28-5 | 200-087-7 | substance | Acute Tox. 3 *; Acute Tox. 3; Acute Tox. 2; STOT RE 1; Aquatic Acute 1 | dermal: ATE = 300 mg/kg bw | oral: ATE = 30 mg/kg bw | Hazard statement codes: H331; H311; H300; H372; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H300; H372; H400 |
| pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine | pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine | 40487-42-1 | 254-938-2 | substance | Repr. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 10 | Hazard statement codes: H361d; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361d; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| quintozene (ISO); pentachloronitrobenzene | quintozene (ISO); pentachloronitrobenzene | 82-68-8 | 201-435-0 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| tecnazene (ISO); 1,2,4,5-tetrachloro-3-nitrobenzene | tecnazene (ISO); 1,2,4,5-tetrachloro-3-nitrobenzene | 117-18-0 | 204-178-2 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| reaction mass of: 4,6-dinitro-2-(3-octyl) phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate; dinocton-6 | reaction mass of: 4,6-dinitro-2-(3-octyl) phenyl methyl carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl carbonate; dinocton-6 | 8069-76-9 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | ||
| trifluralin (ISO) (containing < 0,5 ppm NPDA); α, α, α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA); 2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA); N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0,5 ppm NPDA) | trifluralin (ISO) (containing < 0,5 ppm NPDA); α, α, α-trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine (containing < 0,5 ppm NPDA); 2,6-dinitro-N,N-dipropyl-4-trifluoromethylaniline (containing < 0,5 ppm NPDA); N,N-dipropyl-2,6-dinitro-4-trifluoromethylaniline (containing < 0,5 ppm NPDA) | 1582-09-8 | 216-428-8 | substance | Carc. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H351; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H317; H410 |
| 2-nitroanisole | 2-nitroanisole | 91-23-6 | 202-052-1 | substance | Carc. 1B; Acute Tox. 4 * | Hazard statement codes: H350; H302. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H302 | |
| sodium 3-nitrobenzenesulphonate | sodium 3-nitrobenzenesulphonate | 127-68-4 | 204-857-3 | substance | Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H317 | |
| 2,6-dinitrotoluene | 2,6-dinitrotoluene | 606-20-2 | 210-106-0 | substance | Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H350; H341; H361f ***; H331; H311; H301; H373 **; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H350; H341; H361f ***; H331; H311; H301; H373 **; H412 | |
| 2,3-dinitrotoluene | 2,3-dinitrotoluene | 602-01-7 | 210-013-5 | substance | Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H350; H341; H361f ***; H331; H311; H301; H373 **; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H341; H361f ***; H331; H311; H301; H373 **; H410 | |
| 3,4-dinitrotoluene | 3,4-dinitrotoluene | 610-39-9 | 210-222-1 | substance | Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H361f ***; H331; H311; H301; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H341; H361f ***; H331; H311; H301; H373 **; H411 | |
| 3,5-dinitrotoluene | 3,5-dinitrotoluene | 618-85-9 | 210-566-2 | substance | Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H350; H341; H361f ***; H331; H311; H301; H373 **; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H350; H341; H361f ***; H331; H311; H301; H373 **; H412 | |
| hydrazine-trinitromethane | hydrazine-trinitromethane | 414-850-9 | substance | Expl. 1.1 ****; Self-react. A; Carc. 1B; Acute Tox. 3 *; Acute Tox. 3 *; Skin Sens. 1 | Hazard statement codes: H201; H240; H350; H331; H301; H317. Labelling pictogram and signal word: GHS01; GHS06; GHS08; Dgr. Labelling hazard statements: H201; H240; H350; H331; H301; H317 | ||
| 2,3-dinitrophenol; [1] 2,5-dinitrophenol; [2] 2,6-dinitrophenol; [3] 3,4-dinitrophenol; [4] salts of dinitrophenol [5] | 2,3-dinitrophenol; [1] 2,5-dinitrophenol; [2] 2,6-dinitrophenol; [3] 3,4-dinitrophenol; [4] salts of dinitrophenol [5] | 66-56-8 [1] 329-71-5 [2] 573-56-8 [3] 577-71-9 [4] - [5] | 200-628-7 [1] 206-348-1 [2] 209-357-9 [3] 209-415-3 [4] - [5] | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H331; H311; H301; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H373 **; H411 | |
| 2,5-dinitrotoluene | 2,5-dinitrotoluene | 619-15-8 | 210-581-4 | substance | Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H350; H341; H361f ***; H331; H311; H301; H373 **; H411. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H350; H341; H361f ***; H331; H311; H301; H373 **; H411 |
Official source
Entries are copied exactly as published. Not legal advice; always check the official text.